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ABSTRACT
Cognitive and Affective Correlates of Reproductive Hormones
by
Chandler Marrs
Dr. Douglas Ferraro, Examination Committee Chair 
Professor of Psychology 
University of Nevada, Las Vegas
Approximately 80% of all women experience considerable mood lability in the 
days and weeks following parturition. Many researchers have attempted and failed to link 
postpartal mood changes to reproductive hormones and very little research examines 
perinatal cognitive ability. The goal of this research was to elucidate the pattern of 
cognitive and affective behaviors associated with the elevated hormones of pregnancy 
and the diminished hormones following parturition. The present study compared salivary 
progesterone, dehydroxyepiandrosterone (DHEAS), estrone, estradiol, estriol and 
testosterone with the results from a battery of neuropsychiatrie assessments administered 
to thirty-two healthy, primigravid women at 37 weeks of pregnancy and within the first 
10 days postpartum. Results from this study indicate that cognitive performance is 
impaired across multiple domains both during pregnancy and following parturition. 
Moreover, perinatal mood is adversely related to diminished late pregnancy testosterone 
levels followed by postpartal increases in DHEAS.
Ill
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CHAPTER 1 
INTRODUCTION
Numerous animal studies indicate that steroid hormones exert both genomic and 
nongenomic influence on cellular communication and plasticity in the hippocampus, 
raphe nucleus, basal forebrain, frontal cortex, amygdala and the hypothalamus (Cabrera, 
Bregonzio, Laconi and Mampel, 2002; Hou, Yang and Voogt, 2003; Hsu and Smith,
2002; Johansen, Birzniece, Lindblad and Backstrom, 2002; Keefe, 2002; McEwen, 1998; 
Oades, 1978). While the genomic effects of steroid hormones on cell function have been 
widely researched, particularly in the cases of sexual differentiation and reproduction, 
nongenomic activity has only recently come to the forefront. In addition to regulating 
sexual differentiation and reproduction, researchers are finding that steroids also 
modulate everything from learning, memory, mood and cognitive states to stress response 
and seizure susceptibility, using both nuclear and non-nuclear non-transcriptional 
pathways (Backstrom, Zetterlund, Biom, and Romano, 1984; Baulieu and Robel, 1990; 
Cabrera and Navarro, 1996; Keefe, 2002; McEwen, 1998; McEwen, et al. 2001; Moss, 
Gu, and Wong, 1997).
Nowhere is this more evident than in progesterone's modulation of y- 
aminobutyric acid (A) type (GABAA) chloride (CI-) channels (Foley, et al. 2003; 
Johansen, et al. 2002; Takashima, Kawasaki, Kimura, Fujita and Sasaki, 2002) and 
dopamine (DA) release via n-methyl-d-aspartate (NMDA) glutamate receptors (Cabrera,
1
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et al. 2002; Cabrera and Navarro, 1996; Cyr, Ghribi and DiPaolo, 2000). Progesterone 
and its metabolites are potent positive allosteric modulators of the GABAA chloride 
channel capable of producing dose-dependent effects ranging from sedation to anesthesia 
and even death (Arafat, et al. 1988; Concas, et al. 1997; Johansen, et al. 2002; Selye, 
1946). Similar to the benzodiazepines, progesterone is a powerful sedative, hypnotic, 
anxiolytic and anticonvulsant when administered acutely (Arafat, et al. 1988; Backstrom, 
et al. 1984; Baulieu, 1990; Bitran, Hilvers and Kellog, 1991; Gulinello and Smith, 2003; 
Ghoneim, Henricks and Mewalt, 1984). Furthermore, as with benzodiazepines, chronic 
administration of progesterone produces both psychological and physiological tolerance 
and withdrawal symptoms including a marked increase in anxiety and irritability (Bloch, 
et al. 2000; Costa, Spence, Smith and French-Mullen, 1995; Ghoneim, Henricks and 
Mewalt, 1984; Gulinello and Smith, 2003; Hsu and Smith, 2003; Fujita, et al. 1999).
Numerous animal studies and some human studies suggest that like 
benzodiazepine, progesterone also impairs memory in a dose-dependent and time 
dependent manner (Arafat, et al. 1988; Costa, et al. 1995; Johansen, et al. 2002). 
Conversely, with chronic administration or exposure as tolerance develops memory 
improves (though not entirely to pre-administration levels) until withdrawal, where again 
there is a décrémentai decrease in memory function (Fujta, et al. 1999; Sundstrom, Smith 
and Gulinello, 2003).
Progesterone, via its metabolite allopregnanolone and in conjunction with 
estradiol, modulates the release of DA in both the nigrostriatal and mesolimbic pathways 
via binding to NMDA receptors (Cabrera, et al. 2002; Cabrera and Navarro, 1996; 
McEwen, 1998) and/or by regulating tyrosine hydroxylase levels (Hou, et al. 2003).
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Progesterone eind estrogen differentially bind to NMDA receptors in the hippocampus, 
dentate gyrus, nucleus accumbens and frontal cortex and regulate cellular excitability in a 
time and dose dependent fashion (Cyr, et al. 2000; McEwen, 1998). The ovarian 
hormones' influence on NMDA receptor activity in the hippocampus in general and on 
long-term potentiation in particular is arguably linked to learning and memory functions, 
while the role of progesterone on DA modulation in the nucleus accumbens and striatal 
region is thought to influence several aspects of mood and cognition.
Since human pregnancy is marked by both a rapid and sustained increase in 
ovarian steroid levels and an equally rapid decline following parturition (Buckwalter, et 
al. 2001; Russell, et al. 2001; Harris et al. 1994), it is the ideal model from which to study 
the connection between hormones, mood and mental state. Indeed, many studies have 
linked the precipitous fall in hormones to the elevated rates of anxiety, depression and 
psychosis seen postpartum and during menstruation (Harris, et al. 1994; Meakin, et al. 
1995; Nott, et al. 1976; Sundstrom, et al. 2003; Weick, 1989). However, most human 
studies have found only weak associations among circulating ovarian hormone levels and 
mood and/or mental state (Buckwalter, et al. 1998; Harris, et al. 1994) This is particularly 
interesting in light of the animal research that has clearly and consistently shown a 
relationship between ovarian hormones, memory and behavior (Johansen, et al. 2002; 
Keefe, 2002 ). Additionally, electrophysiological data (Backstrom, et al. 1984; Becker, 
Creutzfelt, Schwibbe and Wuttke, 1982; Hsu and Smith, 2003) further supports a 
relationship between ovarian hormones and cell activity as do cell culture and 
immunochemistry studies (Biggio, et al. 2001; Hsu, et al. 2003; Takashima, et al. 2002). 
In human studies, however, especially in the postpartum mental disorder paradigm, there
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is little evidence beyond what is anecdotally accepted that indicates a clear and consistent 
connection between endocrine changes and alterations in either mood or cognition. This 
suggests a lack of clarity in the physiological indices of endocrine mediated cognitive and 
affective changes, a lack of sensitivity in the testing methods utilized, or both.
The failure to consistently connect steroid hormones to mood or cognition in 
human models is likely due to testing methodology. Most studies suffer from extremely 
small sample sizes, use vastly different measurement tools from one project to the next, 
and assay hormone levels only a limited number of times. Consequently, without a 
sufficient number of subjects, the projects lack the sensitivity to detect any changes. 
Furthermore, without repeated hormonal assays at regularly defined intervals over an 
extended period of time, it is difficult to control for all of the confounding variables 
associated with hormonal regulation (natural circadian rhythms, food intake, sleep, stress, 
etc.). However, when sample size is sufficient and multiple hormone tests are taken over 
an extended period of time at designated intervals, as in the case of the Cardiff Study (n, 
120; Harris, et al. 1994), a trend emerges suggesting that there is an association between 
antenatal progesterone levels and postpartum mood symptoms. A similar but less 
consistent trend emerges linking estradiol to postpartal negative mood (DeNovaes, 
Almeida, Joffe and Cohen, 2001; Nott, et al. 1976; Keuvi, et al. 1983). Unfortunately, 
there is a relative paucity of research addressing the relationship between other prominent 
steroid hormones and mood and even fewer studies that have investigated the relationship 
between perinatal steroid hormones and cognition.
O’Hara and colleagues (1991) found an association between antepartal estriol and 
postpartum blues while Harris et al., (1994) found no significant relationship between
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
cortisol and perinatal depression. Buckwalter, et al. (1999) measured 
dehydroxyepiandrosterone (DHEA) and testosterone as well as progesterone and 
estradiol and showed higher DHEA levels were associated with better mood during 
pregnancy, while elevated testosterone was associated with increased negative mood 
postpartum.
Of the few studies that address the relationship between hormones and cognition, 
the results are mixed, again because of vast differences in testing methodology. Jarrahi- 
Zadeh and colleagues (1969) assessed 85 women both pre- and postpartum using a 
variety of subjective and objective instruments. They found an increased frequency of 
perceived deficit in memory during pregnancy that did not correlate highly with objective 
ratings. However, pregnant women as a group performed significantly more poorly on 
objective tests than when not pregnant; this was particularly evident in tasks that required 
concentration and motor speed. This was later confirmed by Sharp and colleagues in 
1993 who, using a similar subjective/objective measurement design, found that 81% of 
the 48 women tested rated their memory during pregnancy as impaired. Furthermore, 
objective tests of memory performance found that pregnant women did indeed perform 
more poorly on verbal recall tasks as compared to controls. Neither Jarrahi-Zadeh (1969) 
nor Sharp (1993) attempted to link hormones to changes in cognition.
Other studies looking at cognitive changes associated with pregnancy include 
Eidelman et al. (1993) who looked at memory deficits during the immediate postpartum 
period (days 1-3) and found that though memory deficits did appear on day one they 
resolved within three days postpartum. Crawley, et al. (2001) showed that memory 
deficits were only subjectively perceived by women during pregnancy and were
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objectively immeasurable at any time period either during pregnancy or after delivery. 
Recently de Groot, Adam and Homstra (2003) found that selective attention was 
impaired antenatally at 36 weeks but resolved at 32 weeks postpartum. Neither Eidelman 
et al. (1993), Crawley et al. (2001) nor de Groot et al. (2003) measured or compared 
hormone levels to cognitive function, and each used substantially different instruments as 
dependent measures.
To date, Buckwalter and associates (1999) have been the only researchers to 
measure cognitive deficits associated with pregnancy and to attempt to link those deficits 
with hormone levels. Among the battery of neuropsychological assessments utilized, only 
verbal memory was significantly impaired during pregnancy and remained so one month 
postpartum. All other modules tested revealed no statistically significant deficits but did 
show trends of impairment in a number of areas. Furthermore, none of the cognitive tests 
correlated to any of the hormones assayed nor were they correlated to changes in mood. 
However, the changes in mood were correlated to particular hormones, which suggest at 
least a tenable link between hormones and mood. Most notably, elevated DHEA was 
associated with improved mood during pregnancy and elevated testosterone was 
associated with negative mood postpartum. However, as with the other studies 
mentioned, this study suffered from a small sample size (n=19) and took only two 
hormone samples. Moreover, Buckwalter, et al. (1999) and all of the other studies 
mentioned thus far (except the Cardiff study), measured hormone levels via serum or 
plasma. As will be discussed in detail in Chapter 2, neither serum nor plasma is a desired 
medium for measuring what is considered to be the biologically active component of the 
hormone. Salivary assays, such as those that were used in the Cardiff Study, measure the
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biologically active portion of the hormone and thus provide a more sensitive assessment 
tool.
Finally, like all of the studies that preceded it, the Buckwalter et al. (1999) study 
used a standard battery of neurocognitive instruments that, while adept at measuring the 
gross cognitive deficits associated with traumatic or vascular injury, are relatively 
incapable of detecting what are likely to be subtle changes in function. Moreover, aside 
from measuring verbal memory which has been shown to be influenced by high levels of 
progesterone, this and all of the other studies failed to choose tools that measure other 
cognitive domains theoretically associated with chronically high levels of ovarian 
hormones.
Recall from the discussion above that progesterone is a potent positive allosteric 
modulator of GABAA Cl- channels. Like benzodiazepine it is a powerful sedative, 
anxiolytic, anticonvulsant and, at strong enough doses, can be an anesthetic (Arafat, et al. 
1988; Concas, et al. 1997; Johansen, et al. 2002; Selye, 1946). Also like benzodiazepine, 
progesterone though its extensive metabolites has an extended half-life (Baulieu, Robel, 
1990; Keefe, 2002; McEwen, 1998); and it is capable of producing both psychological 
and physiological withdrawal symptoms (Bloch, et al. 2000; Costa, et al. 1995; Fujita, et 
al. 1999; Ghoneim, et al. 1984; Gulinello and Smith, 2003; Hsu and Smith, 2003). 
Furthermore, progesterone like the benzodiazepines shows a strong affinity for GABAA 
receptors in the hippocampus, and has been found in the raphe nucleus, nucleus 
accumbens, striatum, amygdala, frontal cortex and the hypothalamus (Bixo, Andersson, 
Windblad and Backstrom, 1997). Given as well that that progesterone enhances the 
release of DA in the striatum (Cabrera, et al. 2002; Cabrera and Navarro, 1996) and
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nucleus accumbens, it is easy to infer a pattern of behaviors congruent with chronic 
progesterone exposure/withdrawal.
The sedative properties of progesterone predict changes in concentration, 
attention, motor and/or cognitive slowing. Its anxiolytic properties should reduce anxiety 
during pregnancy but increase anxiety after delivery, during the withdrawal phase. Its 
affinity to GABAA receptors in the hippocampus should affect learning and memory 
(McEwen, 1998), especially where processing speed is involved, while its presence in the 
raphe nucleus might alter arousal and excitability (Klink, Robichaud and Debonnel,
2002; Oades, 1978). The increase in circulating DA during pregnancy, particularly in the 
nucleus accumbens should increase motivational or pleasure-seeking activities as an 
addictive drug might. The precipitous decline in DA after delivery, however, should 
cause a bevy of withdrawal type symptoms, including increased anxiety. Since one of the 
major projection pathways from the nucleus accumbens is to the frontal cortex, the 
decline in both G ABA and DA should have adverse effects on planning, organization and 
executive function as well as affect regulation, particularly with regard to social judgment 
and motivation via its connections with the amygdala and other limbic structures. In fact, 
when one compares the personality and cognitive changes associated with prefrontal 
cortex injuries to those associated with postpartum depression, a strikingly similar 
although more subtle, pattern emerges, particularly when one considers the executive 
dysfunction and mood lability reported by many pregnant and postpartum women. Yet 
there is no convincing evidence linking steroid hormones to changes in human cognition 
and affective regulation either during or after pregnancy.
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With the above in mind, it is the purpose of this study to explore the connection 
among multiple steroid hormones and cognitive and affective functioning in pregnant and 
postpartum women. The present research utilized a battery of neuropsychological 
instruments sensitive to subtle changes in both cognitive and affective functioning, as 
well as salivary hormone assays capable of measuring the biologically active component 
of the hormones. The range of hormones measured was expanded to include not only 
progesterone and estradiol, but estrone and estriol, as well as DHEAS and testosterone. 
By increasing the sensitivity of the psychological assessment tools and the hormonal 
assays, it is predicted that a clear link between steroid hormone levels and cognition and 
steroid hormone levels and affective regulation will be rendered.
To summarize, the goals of this research are to identify: 1) cognitive and 
emotional changes associated with chronically elevated levels of steroid hormones during 
pregnancy, 2) cognitive and emotional changes associated with the rapid withdrawal of 
hormones postpartum, and 3) to identify biological markers of perinatal mood 
dysfunction.
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CHAPTER 2
LITERATURE REVIEW 
Animal studies have clearly and consistently shown a link between hormones and 
memory and, as much is possible, between hormones and affective behavior. But the data 
in human studies is inconclusive for a number of reasons. First, experimental design in 
animal studies is typically more tightly controlled and technical procedures are more 
invasive than is ethical with human subjects. Secondly, human studies more often than 
not have extremely small samples, often precluding the possibility of finding significant 
results. Thirdly, measures of cognitive and affective behavior are relatively limited in 
animal studies compared to the number of measures available in human research; thus 
very rarely do any two human studies use the same instruments. Fourthly, because the 
relationship between hormones, mood and cognition is a topic outside the purview of 
most disciplines, there is a paucity of human research compared to what is available in 
the animal literature. Finally, the lack of research and the interdisciplinary nature of the 
topic have created a real vacuum of understanding. Not only are there relatively few 
experts in steroid endocrinology, compared to the vast numbers in peptide endocrinology, 
but there are even fewer who are interested in the connection between hormones mood 
and cognition. Likewise, those who study mood and cognition very rarely consider the 
possibility that steroid hormones might influence the expression of either.
10
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Given the lack of human research on the role of hormones, cognition and affective 
regulation, it might be useful to provide a fair amount of background information prior to 
reviewing the psychological literature. Indeed, a significant portion of this section will 
focus on the neuromodulatory role of steroid hormones in addition to the physiological 
components of the system itself. Since some of the most exciting research challenges 
many commonly held beliefs regarding steroid synthesis and intra-nuclear mechanisms of 
action, a basic review of these processes is also provided. After all the background 
information is presented, a thorough review of relevant literature is given, with emphasis 
on integrating information gleaned from animal studies and the overview of steroid 
endocrinology with data from human models.
The Endocrine System and the HPO Axis 
The endocrine system utilizes hormones as a means of communication between 
the cells and tissues. Its primary purpose, together with the nervous system, is to maintain 
biological homeostasis. To that end, hormones are secreted directly into the circulatory 
system by the hypothalamus and the pituitary to various target glands including the 
adrenal, the thyroid, the testis and the ovaries. Through a series of both positive and 
negative feedback and feed forward loops, called circuits or axes, the endocrine system 
regulates hormone synthesis and secretion which in turn regulates energy metabolism, 
reproduction and growth (Niewoehaner, 1998). The hypothalamus is the primary 
integrator of the endocrine system and in conjunction with the pituitary modulates the 
hormonal secretion and synthesis that regulates the action of the autonomic nervous
1 1
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system and the functioning of virtually all bodily organs (Martin, 1996: Niewoehaner, 
1998).
The hypothalamus along with the pituitary and the ovaries form a circuit called 
the HPO axis. Together they regulate the menstrual cycle and support pregnancy. During 
the menstrual cycle, the hypothalamus stimulates the pituitary's release of luteinizing 
hormone (LH) and follicle stimulation hormone (FSH) by releasing the gonadotropin- 
releasing hormone (GnRH). The release of hypothalamic GnRH causes the pituitary to 
release FSH and LH. As the follicle develops, FSH and LH stimulate the release of 
estradiol which ultimately inhibits continued FSH secretion. Concurrently, the release of 
estradiol causes the increase of LH, which in turn causes the release of more estradiol. 
Estradiol levels peak immediately before ovulation; this peak signals the decline of 
GnRH and LH levels at ovulation on about day 15 of the cycle. This part of the cycle is 
called the follicular phase. After ovulation, during the luteal phase, estradiol levels wane, 
while progesterone levels increase until day 21-23 when the corpus luteum forms. A 
couple of days later, the endometrium sheds and menstruation begins (Schwartz, 2000; 
Starr and McMillan, 1997). Estradiol reaches a second peak, simultaneously with the 
progesterone peak at days 21-23 (Kaplan, Pesce and Kazmierczak. 2003). If there is a 
viable follicle and fertilization occurs, estradiol continues to increase (along with estriol 
and estrone) and there is a surge in LH. After implantation, the fetoplacental unit begins 
secreting human chorionic gonadotropin hormone (B-hCG) which will maintain the 
corpus luteum and endometrium throughout the pregnancy. Elevated estradiol levels then 
suppress FHS secretion (Neal, 2002; Schwartz, 2000).
12
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During a normal menstrual cycle plasma estrogen levels range from 
approximately 143-694 pmol/1 in the follicular phase to 176-1134 pmol/1 in the luteal 
phase (Griffin and Ojeda, 2000; Thompson, Sergejew and Kulkami, 2000). During 
pregnancy total estrogen levels increase to 15,000 pmol/1 (Illingworth and McNeilly, 
1998) and immediately following delivery they fall very close to zero (Illingworth and 
McNeilly, 1998). Progesterone levels range from .6-2.6 nmol/1 in the follicular to 13.2- 
75.2 nmol/1 in the luteal phase (Griffin and Ojeda, 2000; Thompson, et al. 2000). 
Progesterone levels can rise to over 800 nmol/1 during pregnancy and fall to as low as 2.7 
nmol/1 following delivery (Harris, et al. 1994; Illingworth and McNeilly, 1998).
It is important to notice three aspects of this system. First, even during the normal 
menstrual cycle, women generally experience at least a 2-fold increase in both estrogen 
and progesterone, which is significant in and of itself. But during pregnancy the increase 
for both hormones is exponential. Secondly, as with all hormones, ovarian hormones are 
released into the blood-stream where they must travel great distances to reach their target. 
Since there are estrogen and progesterone receptors located throughout the central 
nervous system (CNS), it is likely that a good percentage of these hormones bind with 
receptors in areas other than the hypothalamus and thus may be involved in functions 
other than reproduction. Thirdly, if ovarian hormones bind with other receptors in brain 
regions not directly associated with reproduction, then it stands to reason that the cyclical 
shift in hormones might have behavioral and/or cognitive correlates. Some evidence 
suggests that this is the case. For example, the rise and fall of estrogen is associated with 
both a cyclical potentiation and downregulation of dendritic growth and synaptogenesis 
in rat hippocampal cells both in culture and in vivo. Subsequent behavioral tests given
13
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during different times of the rat estrus cycle mirror the pattern of growth and 
downregulation with increased efficiency in the Morris water maze test during periods of 
high estrogen and increased deficits during the high progesterone period (McEwen, et al. 
2001). Human studies in the premenstrual syndrome paradigm suggest that there are both 
emotional and cognitive changes associated with the female menstrual cycle. Studies 
have shown that in the late luteal phase of the menstrual cycle, when progesterone levels 
are falling, anxiety increases rather significantly in some women (Poromaa, Smith and 
Gulinello, 2003). Cognitive researchers have shown that high levels of estrogen correlate 
with diminished performance on tests of spatial ability (Hampson, 1990) and improved 
performance on tests of verbal memory (Maki, Zonderman and Resnick, 2001; 
Hogervorst, Boshuison, Reidel, Willeken and Jolies, 1999).
Finally, cataménial epilepsy as well as other forms of epilepsy, are either initiated 
and/or exacerbated both during the follicular phase of the menstrual cycle when estrogen 
is elevated and in the late luteal phase of menstruation when progesterone levels drop 
significantly (Morrel, 1999). Electrophysiological data confirms that during the follicular 
phase, women show an increase in spike frequency, particularly in the hippocampus and 
in other regions of the temporal lobe where epileptogenesis is thought to evolve 
(Backstrom, et al.; 1984; Backstrom, 1976; Becker, Cruetzfeldt, Schwibbe and Wuttke 
1982). Overall, researchers suggest that estrogen acts as an excitatory agent while 
progesterone is considered inhibitory.
Given the fact that hormones are released into circulation and travel great 
distances to reach their target combined with the possibility for hormone binding in 
regions not associated with reproduction, one would expect an abundance of evidence
14
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linking changes in circulating hormones to changes in behavior and cognition. The above 
studies, particularly McEwen et al. (2001) and their work on estrogen and synaptogenesis 
and the epilepsy research certainly suggest that hormones modulate brain function in 
some fairly significant ways, but there is very little research in this area. Therefore, 
before discussing additional evidence linking the rise and fall of ovarian hormones to 
behavioral and cognitive changes, particularly during pregnancy where the changes are 
substantial, it might be helpful to review hormone synthesis, metabolism and 
neuromodulatory capabilities.
Peripheral Ovarian Steroid Synthesis and Metabolism
Synthesis
Standard tables of steroid hormone synthesis show the pathway listed in Figure 1. 
All steroid hormones are synthesized from cholesterol. Cholesterol is synthesized from 
acetate in the liver as well as from other cells throughout the body utilizing starches 
and/or fats. In the ovaries and adrenals, cholesterol is transformed into pregnenelone, the 
precursor for progesterone. The by-product of pregnenelone's conversion to progesterone 
is pregnenelone sulfate (PS), not listed in figure, but a potent neuromodulator in its own 
right.
The fate of progesterone is tissue and enzyme dependent (Hillier, 1998). 
Progesterone biosynthesis in the ovaries leads to production of 17- OH-progesterone, 
androstenedione, testosterone, and the three (there are twenty in all) primary estrogens 
estrone (El), estradiol (E2), estriol (E3). Progesterone in the adrenals leads to the 
synthesis of deoxycorticosterone, corticosterone, aldosterone and eventually cortisol
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(Hillier, 1998). The female and fetal adrenals also produce DHEA which is then 
converted first to DHEAS (sulfate) and then to estrone and estradiol (Russell, et al.
2001). Progesterone is also synthesized by glial cells in the central nervous system and by 
Schwann cells in the periphery, both in the absence of ovarian function (Keefe, 2002; 
Hillier, 1998).
Unlike the other steroid hormones, progesterone is further metabolized in the 
ovaries, adrenals and other tissues as well as in the central nervous system producing 
very active metabolites. Research shows that at least six of progesterone's 20 metabolites 
directly modulate neurotransmission (Table 1). Some of the more potent metabolites of 
progesterone found in animal studies include pregnanedione, 3a and 5a- 
tetradehydroxydioxycoticosterone, (derived from corticosterone pathway) and 
allopregnanolone, (3a-OH-pregnan-20-one). Pregnanedione is the end product of 
progesterone metabolism and allopregnanolone is formed from the 5a-reduced 
metabolite 5a-DHP or P3 (Bixo, et al. 1997). Arafat et al. (1988) found 5a-Pregnan-3a- 
ol-20-one (P4) and 5 [3-Pregnan-3 a-ol-20-one (P6) to be the most abundant progesterone 
metabolites found in human plasma when measured via gas chromatography-mass 
spectrometry. Animal studies suggest that allopregnanolone, (3a-OH-pregnan-20-one), is 
the most abundant and potent progesterone metabolite. It is not clear if allopregnanolone 
was measured in the Arafat et al. study.
Measures performed on extracted human postmortem brain tissue showed 
significant levels of progesterone, allopregnanolone and 5a-DHP throughout the cerebral 
cortex, particularly in the hypothalamus, limbic system, brainstem, basal ganglia and 
cerebellum (Bixo, et al. 1997). The amygdala, the cerebellum, hypothalamus and nucleus
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accumbens show the highest concentrations of progesterone, while the substantia nigra 
and the basal hypothalamus show the most allopregnanolone and 5a-DHP. Bixo et al. 
suggested that the discrepancy in distribution may be related to the fact that progesterone 
is metabolized in two separate steps, progesterone to 5a-DHP in neurons and 5a-DHP to 
allopregnanolone in astrocytes.
Hormone Production
The production rate for estradiol in a normal cycling woman ranges from 100- 
600ug p/day depending upon the day of the cycle and the weight of the woman, with 
obese women producing up to two times the amount of estrogen (Faigle and Schenkel, 
1998). The most potent of the estrogens are estradiol and estrone followed by estriol, 
which is consistent with their metabolic pathways.* However, during pregnancy estriol is 
most abundant (Kaplan, Pesce and Kazmerczak, 2003; Solomon and Fuchs, 1971).
The production rate of progesterone in non-pregnant women ranges from 15- 
20mg p/day in the luteal phase and falls to less than 5% of those values during the 
follicular phase (Faigle and Schenkel, 1998). Plasma levels range from 5- 20ng/ml 
depending upon the stage of the cycle. Progesterone's peripheral half-life is extremely 
short, approximately 30 minutes, but its metabolism produces several highly potent 
derivatives, which effectively extend the actions of the steroid. There are, however, 
indications that CNS levels of progesterone and its metabolites are maintained at steady 
and in some cases higher levels than those measured in circulation, even in the absence of 
ovarian or adrenal synthesis (Baulieu, 1991; Papadopoulos, et al. 1991).
' Reverse oxidation o f  estradiol results in estrone (17(3HSD), which is then hydroxy lated and produces 2- 
hydroxyestrogens (catecholestrogens) and 16 a - hydroxyestrogen. 16a- hydroxyestrogen reduction by 
17(}HSD yields estriol (Hillier, 1998).
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During pregnancy both the mother and the fetoplacental unit produce estrogen 
and progesterone^. The placenta alone cannot convert pregnenolone to either 
progesterone or estrogen, so pregnenolone is transferred from the placenta to the fetus 
where it is synthesized into progesterone and then to the estrogens (Beling, 1971). During 
the first six weeks of pregnancy, maternal or ovarian production of progesterone 
predominates. Between the sixth and eight week, the fetoplacental unit becomes the 
primary source of progesterone (Challis and Lye, 1998). Fifty percent of maternal plasma 
estrone and estradiol are synthesized by the fetal adrenal gland and 50% is synthesized 
from maternal DHEA. Up to 90% of maternal estriol is produced by the fetus via 
hydroxylation of DHEAS in the fetal liver (Challis and Lye, 1998). Estriol is the primary 
estrogen during pregnancy, and is thought to ensure continued uteroplacental blood flow. 
Abnormally low estriol generally indicates fetal distress (Kaplan, et al. 2003). Plasma 
levels of estriol range from 16-23ug/100ml during the last three weeks of pregnancy 
(Kaplan, et al. 2003).
Both the mother and the fetoplacental unit produce estrogen and progesterone 
from the beginning of pregnancy up to 6-8 weeks of gestation, after which the 
fetoplacental unit takes over. The rate of fetoplacental progesterone production (as 
measured by radio labeling progesterone in the placenta) near the end of pregnancy can 
be as high 322mg for a singleton and up to 522mg for twins (Solomon and Fuchs, 1971). 
After delivery of the placenta, production of progesterone by the fetoplacental unit ceases 
and maternal production does not resume fully for several weeks.
 ̂O f interest, pregnenolone, the precursor for both progesterone and estrogen is converted to pregneneione 
sulfate in large amounts by the placenta. Pregnenolone sulfate, is a potent neuromodulator o f  both the 
G ABA and DA systems (Valle, Gingras, Le Moal, Mayon and Piazza, 1999).
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Protein Binding and Hormone Measurement
Both the estrogens and progesterone are highly bound to proteins in the blood.
The estrogens are highly bound to albumin (estradiol - 60%, estrone - 80% and estriol - 
91%) and sex hormone-binding globulin (estradiol - 3 7%, estrone -  16%, estriol -1%). 
The amount of free hormone, considered the biologically active portion of the hormone is 
relatively small (estradiol -1.8%, estrone- 3.6%, estriol- 8.1%) (Longcope, 1998). 
Progesterone is also bound to circulating proteins and albumin. Progesterone is primarily 
bound to cortisol binding globulin and albumin and some glycoproteins, especially during 
pregnancy. The percentage of free progesterone, thought to represent the biologically 
active fraction, is 1-10% of total plasma concentration (Steimer, 2004).
Protein binding is important for a number of reasons. In most of the human 
research, hormones are assayed via plasma or serum, which measures hormones bound to 
protein. Hormones bound to protein are not biologically active (Griffen and Ojeda, 2000), 
that is, they are not free to bind to receptors and initiate changes in the cell. On the other 
hand, unbound hormone represents that portion of the circulating hormone that is 
biologically active. Unbound hormone can either bind to receptors or be metabolized 
into component parts and thus is thought to represent a more direct measurement of 
hormone activity (Lu, et al. 1999).
The most common measure of hormone is via radioimmunoassay (RIA) using 
serum samples. RIA uses the binding of radio-labeled antigens (Ag) (hormone) to 
antibodies (Ab) by an unlabeled antigen to measure the Ag:Ab reaction. Since unlabeled 
hormone inhibits binding of the radiolabeled hormone, the amount of radioactivity 
measured is inversely proportional to the amount of hormone in the sample: lower
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concentrations of radioactive hormone equal higher concentrations of unlabeled hormone 
(Griffen and Ojeda, 2000). Another technique is the enzyme-linked immunosorbent assay 
(ELISA) also called the enzyme immunoassay (ElA). This project is using the ELISA 
method. ELISA utilizes the same basic technique as the RIA except that it introduces an 
enzyme labeled Ag to the equation. The Ag:Ab reaction is then measured by the color 
change of the enzyme. ELISAs have several benefits over RlAs, namely ELISA 
produces no radioactive waste and is easier and less expensive to perform.
Steroids and the Brain
Classic Nuclear Receptors
After synthesis in the ovaries, metabolism in the liver, progesterone and 
progesterone derivatives enter systemic circulation where, because of high lipid 
solubility, they easily cross the blood brain barrier. Upon crossing the blood brain barrier, 
ovarian hormones travel to the hypothalamus where they modulate hypophysiotrophic 
factors such as the release of the pituitary hormones like GnRH, thereby completing the 
feedback loop in reproductive management (Baulieu and Robel, 1990).
Steroid hormones are believed to exert their influence on the cell via binding to 
receptors in the cytoplasm. Once in the cytoplasm they are transported into the nucleus 
where the hormone receptor complex activates transcription factors and triggers RNA- 
dependent protein synthesis (Keefe, 2002; Jennes and Langub, 2000; Moss, et al. 1997). 
Estrogen and progesterone work synergistically to regulate reproductive function. The 
presence of estrogen in the cell increases the number of progesterone receptors and the 
presence of progesterone decreases the number of estrogen receptors (Keefe, 2002).
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Until recently, genomic activity in the hypothalamus, which regulates 
reproduction and sexual differentiation, was considered the sole purpose of ovarian 
hormones. However, new research shows that not only are there estrogen and 
progesterone receptors located throughout the brain, but post-mortem human studies have 
found significant levels of both hormones in areas of the brain where no nuclear receptors 
have been identified (Bixo, et al. 1997). These findings are supported by postmortem 
animal studies using light microscopic immunochemistry and autoradiography techniques 
(McEwen, et al. 2001). This indicates that the ovarian hormones, particularly 
progesterone, may be involved in functions other than reproduction and sexual 
differentiation and may exert their influence via non-genomic means. It also suggests 
that sexual differentiation extends beyond simple reproductive physiology and into neural 
dimorphisis^, perhaps underlying the differential etiologies in many disorders. Indeed, 
many researchers contend that gender dimorphisis in central nervous system structures is 
far more widespread than is currently understood and that "we should consider all regions 
dimorphic until proven otherwise'*," (Payne, 1996). If this is the case then one must ask 1) 
what brain regions are affected by ovarian hormones? 2) By what mechanism is action 
elicited? 3) What are the concomitant effects on behavior?
^Several brain regions show gender-specific dimorphism in morphology and functioning. For example the 
male (rat) raphe nucleus shows a lower density o f  receptors but fires at a much higher rate than do the 
neurons in the female raphe nucleus (Fink, et al. 1998). Furthermore, female rats show higher levels o f  
synthesis and turnover than male rats.
" In an interesting study by Wood and Shors (1998) researchers found that estrogen mediated stress induced 
classical conditioning in female but not male rats. Stress (tail shock) facilitated the conditioned eye blink 
responses in the male rats but impaired acquisition in the female rats. When estrogen was removed from the 
equation via ovariectomy (OVX), acquisition o f  the conditioned response improved in female rats. 
Conversely when estrogen was added back to the OVX rats, acquisition was again impaired.
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Endocrine Targets in the Brain
Animal (rodent) research has found estrogen in multiple regions throughout the 
brain where few or no classic estrogen receptors exist. These areas include CAl region of 
the hippocampus, the dorsal raphe nucleus and the basal forebrain (McEwen, 1998). In 
the hippocampus, for example, both estrogen and progesterone exert profound influence 
on cell function. Morphologic studies with female rats found that estrogen treatment 
initiated dendritic spine growth and synaptogenesis on the pyramidal neurons in the 
hippocampus (McEwen, et al. 1997). Moreover, the growth was cyclical and ephemeral 
and closely followed the estrus (menstrual) cycle. The new dendrites and synapses were 
broken down during the later half of the luteal phase of the cycle only to return again 
during follicular phase (McEwen, et al. 1997).
The critical factor in synaptogenesis and dendritic growth was the rise and fall of 
estrogen in relation to progesterone. During the follicular phase, estrogen levels increase 
and spine-formation begins. When the progesterone level begins to increase in relation to 
estrogen, spine formation is rapidly potentiated, but as estrogen levels off and 
progesterone levels continue climbing, spine formation is quickly downregulated. When 
progesterone levels decline or are removed, complete downregulation of synaptic growth 
occurs within 8-12 hours; when estrogen is the only variable being added and removed, 
spine downregulation occurs much more slowly, over the course of days after its 
withdrawal  ̂ (McEwen, et al. 1997).
In addition to its activity in the hippocampus, progesterone has been measured in 
a variety of regions throughout the CNS. For example, a postmortem study of five
 ̂ Studies with male rats showed that estrogen administration failed to induce as much dendritic growth as 
was seen in female rats. Researchers suggested that the likely distinguishing factor was testosterone.
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women measuring 17 brain regions and serum progesterone, 5a-prenane-3,20-dione 
(5aDHP) and 3a-hydroxy-5a pregnane-20-one (allopregnanolone) levels found high 
levels of progesterone in the amygdala, cerebellum, frontal cortex, hippocampus and 
hypothalamus. The highest levels of 5a-DHP and allopregnanolone were found in the 
substantia nigra and hypothalamus. What was particularly interesting was that 
progesterone levels correlated with 5a-DHP and not allopregnanolone, but 5a-DHP 
correlated with allopregnanolone (Bixo, et al. 1997). This supports the idea that central 
nervous system conversion of progesterone to allopregnanolone involves two separate 
steps and may occur in different regions of the brain. Other studies have suggested that 
the conversion from progesterone to 5a- DHP takes place in the neurons while the 
conversion of 5a-DHP to allopregnanolone occurs mainly in the astrocytes (Martini, 
Melcangi and Maggi, 1993).
Neurosteroids
If progesterone and estrogen are present in the brain in regions not traditionally 
associated with reproduction then the question becomes, what are they doing there? 
Moreover, if there are no nuclear estrogen or progesterone receptors in these areas by 
what means do these hormones influence cell function, if at all?
Recall from above that in addition to the peripheral synthesis of ovarian hormones 
both neurons and glial cells can and do synthesize some steroid hormones. These 
steroids, called neurosteroids can be synthesized in the brain de novo and irrespective of 
peripheral steroid synthesis (Baulieu, 1991). Neurosteroids are divided into two classes, 
active and inactive. Inactive neurosteroids are steroids that are synthesized in the nervous 
system but are not active on neural tissue (Stofel-Wagner, 2001). Active neurosteroids or
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neuroactive neurosteroids are synthesized in the nervous system and actively modulate 
neural tissue. Pregneneione (progesterone precursor), pregneneione sulfate (conversion 
by-product), progesterone and at least six of its derivatives are considered neuroactive 
neurosteroids. The adrenal steroid DHEA, its sulfated ester DHEAS (estrogen 
precursor), and l?P-estradiol are neuroactive steroids but it is not clear whether they can 
be synthesized in the nervous system de novo.
Both neurosteroids and neuroactive steroids exert their influence on 
neurotransmitter systems via genomic and non-genomic means (Stofel-Wagner, 2001). 
Recall that traditional genomic theory holds that the molecule diffuses across the 
membrane, binds to a receptor and the hormone receptor complex moves into the nucleus 
where it activates gene transcription and some sort of response. Genomic activity is 
thought to take hours to days to complete. However, some hormones, particularly 
progesterone and DHEAS, are able to elicit neural and behavioral changes within seconds 
to minutes of exposure. This led researchers to explore the possibility that neurosteroids 
bind to membrane receptors, rather than cytoplasmic or intranuclear receptors, and 
modulate cell behavior via other means. In fact, this has proved true. Estrogen is capable 
of modulating synaptogenesis and dendritic growth in hippocampal CAl pyramidal cells 
without any recognized nuclear receptors (McEwen, 1998), while progesterone and its 
derivatives bind to ligand channels and initiate both simple ionotropic and G-protein 
coupled responses depending upon the chronicity of exposure.
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Neurosteroids and Neurotransmitters
Neurosteroids modulate each neurotransmitter system to some degree or another. 
Research shows that the estrogens, DHEAS and progesterone are particularly potent 
neuromodulators. Below is a review of the more significant effects of the estrogens, 
progesterone, DHEAS and testosterone on the central nervous system.
Estrogen
Research shows that estrogen, in addition to initiating dendritic growth and 
synaptogenesis in the hippocampus, modulates cholinergic neurotransmission from the 
basal forebrain to the hippocampus via acetyltansferase induction (McEwen, 1998). In 
female rats estrogen increases the expression of serotonin type 2a (5HT2A) receptors and 
the 5HT transporter in the dorsal raphe nucleus (DRN) by as much as 50% (Fink, et al.
1998), suggesting a possible role of estrogen in the treatment of depression. In fact, some 
clinicians have effectively reduced the incidence of postpartum depression in women 
with previous histories of the disorder by administering estrogen in the weeks following 
delivery (de Noaves-Soares, et al. 2001). In perimenopausal women, estrogen 
replacement therapy appears to ameliorate symptoms of depression (de Novaes-Soares, et 
al. 2001) as well as improve verbal memory (Maki, Zonderman and Resnick, 2001 ; 
Hogervorst, et al. 1999; Hogervorst, Yaffe, Richards and Huppert 2002; Kampen and 
Sherwin, 1994; Sherwin, 1994).
In postmenopausal women, estrogen administration inereases the 5HT2A density 
in the anterior cingulate, olfactory and frontal cortices as well as in the DRN (Moses, et 
al. 2000). Estrogen also regulates DA transmission in the tuberoinfundibular (TIDA) 
region of the hypothalamus (Hou, et al. 2003) and is correlated with tyrosine hydroxylase
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mRNA expression in the brainstem as well as in both the nigrostriatal and mesolimbic 
DA pathways (McEwen, 1998).
The cognitive correlates of the rise and fall of estrogen have been studied 
extensively in both human and animal models. In postmenopausal women estrogen 
replacement therapy improved memory function, particularly verbal memory 
(Hogervorst, et al. 1999; Hogervorst, et al. 2002; Kampen and Sherwin, 1994; Maki, 
Zonderman and Resnick, 2001; Sherwin, 1994). In normally cycling women, higher 
levels of estradiol during the late follicular phase corresponded to higher scores on tasks 
involving verbal and fine motor skills, but lower scores on spatial tasks. Conversely 
during menstruation when levels of both progesterone and estrogen are low, spatial skills 
improved (Hampson, 1990). In a small study looking at the effects of a GnRH agonist 
(estrogen antagonist) on memory, it was found that 7 of 16 women reported moderate to 
marked memory impairment during the final weeks of treatment. Prospective memory 
was most impaired (Newton, Slota, Yuzpe, Tumman, 1996). This is further supported by 
estrogen replacement therapy (ERT) in postmenopausal women where verbal memory 
was significantly improved in women receiving ERT compared to those who did not 
(Hogervorst, et al. 1999; Hogervorst, et al.; Maki, et al. 2001; Sherwin, 1994). 
Progesterone
Progesterone, in addition to potentiating many of the changes associated with 
estrogen, actively modulates GABAergic, dopaminergic and glutaminergic transmission 
and does so primarily through nongenomic means. It is these changes that appear to be 
most closely linked to the affective and cognitive deficits associated with pregnancy and 
postpartum and for that reason are discussed in detail below.
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GABA
GABA is the primary inhibitory neurotransmitter of the central nervous system 
with diffuse projections throughout the brain. Located in intemeurons, GABA has two 
types of receptors: the simple ionotropic GABAA receptor and the G-protein coupled 
GABAB receptor. Progesterone and several of its metabolites are potent positive 
allosteric modulators of the GABAA Cl- channels (Bitran, et al. 1991 ; Puia, Ducic, 
Vincini and Costa, 1992). Like benzodiazepines, progesterone binds to membrane 
receptor sites, this increases the receptor's affinity for endogenous GABA and increases 
the frequency of channel openings, thereby increasing the influx of GABA itself (Nestler, 
Hyman and Malenka, 2000; Smith, 2001).
During short-term administration, progesterone via allopregnanolone is 
considered a more effective modulator of GABAA than any of the BDZs (Arafat, et al. 
1988; Backstrom, et al. 1984; Bitran, et al. 1991; Baulieu, 1990; Ghoneim, et al. 1984; 
Gulinello and Smith, 2003). Acute administration of progesterone or its derivative 
allopregnanolone is highly sedative and produces dose dependent decrements in learning 
and memory in most animal models.
Chesler and Juraska (2000) found that combined estrogen and progesterone 
administration in ovariectomized rats produced deficits in Morris water maze acquisition 
but that neither produced deficits when administered alone. The Morris water maze is 
presumed to measure aspects of spatial/reference, working and long-term memory. Frye 
and Sturgis (1995) found that the progesterone metabolite allopregnanolone increased the 
latency and decreased the number of correct choices in the Y maze test. Johansen et al. 
(2002), found that male rats injected with allopregnanolone performed significantly
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worse on the Morris water maze test than did those injected with vehicle only. Guilinello 
and associates (2003) found that female but not male rats show an elevated startle 
response after progesterone withdrawal, but without differences in sensorimotor gating.
Unfortunately no such study exists comparing acute progesterone administration 
and human cognitive deficits. But because of its similarity in actions to the 
benzodiazepines (BDZ) we can infer the types of deficits that might occur. Ghonneim, et 
al. (1984) tested immediate and free recall in 120 subjects after administration of 
diazepam (placebo, Img, 2mg, 3mg). Each group was tested three times after consuming 
the drug. The results showed a consistent decline in performance as the dose increased. 
Furthermore, at the higher dosage not only was the magnitude of the decline in 
performance greater, but the recovery duration was extended as well. Weingartner, et al. 
(1992) found that triazolom administration impaired recognition and free recall but not 
other aspects of explicit memory.
In a study measuring the sedative properties of orally administrated progesterone, 
Arafat et al. (1988) found significant impairment of mental state in women two hours 
after oral administration of 200mg and 400mg of micronized progesterone. Using gas 
chromatography-mass spectography, researchers were able to measure the metabolites 
formed from serum samples and found that the women who experienced the most severe 
sedation formed the highest number of metabolites. But not all women formed all 
metabolites, suggesting a possible sensitivity to progesterone in some women but not 
others. Furthermore, given the severity of the sedation in some women, had the 
researchers tested cognitive function, they might have found similar decrements in 
memory as those described in the BDZ literature.
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If progesterone and BDZ impair memory in acute doses, what happens during 
chronic exposure, particularly when the levels are rapidly and continuously increased 
over the course of an extended period of time, such as during pregnancy? The answer to 
this question involves a more thorough understanding of the GABAergic system.
GABA Subunit Composition and Mood, Memory and Mental State
Recall from above that progesterone binds to a receptor site located on the 
GABAA Cl- channel, and that binding increases the cell's affinity for endogenous GABA 
as well as increasing the channel open time. Acute administration of a single dose of 
progesterone elicits a rapid response that dissipates rather quickly if no further dosing 
occurs. However, because progesterone metabolism includes an extensive list of very 
active metabolites continued dosing or exposure not only extends the steroid's half-life, 
but induces changes in cell morphology consistent with physiological tolerance 
(Gulinello and Smith, 2003). Unlike the other cells that respond to activity changes via 
receptor up or down-regulation, the GABA cell responds by changing the conformation 
of the receptor itself (Hsu and Smith, 2002; Izzo, 2000; Puia, Ducic, Vincini and Costa, 
1992).
GABAA receptor composition is mediated by the arrangement of a complex 
combination of subunits. There are at least 16 and up to 19 subunits (Fuji and Mellon, 
2001; Smith, 2001) currently identified that are grouped into seven functionally distinct 
families (Nestler, et al. 2000), which depending upon conformation, alter the behavior of 
the GABA cell. For example, the sedative-hypnotic effects of BDZs are mediated by 
binding to the a-1 subunit, while the a-2, a-3, a-5 subunits are thought to mediate the 
anxiolytic effects of the drug (Biggio, Follesa, Purdy and Concas, 2001; Poromaa, Smith
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and Gulinello, 2003). Conversely, a-4, and a-6 subunits are insensitive to BDZ and are 
thought to elicit anxiogenic behavior when present in greater numbers than the a-1, a-2, 
a-3 and a-5 subunits (Biggio, et al. 2001; Poromaa, et al. 2003; Wafford, et al. 1996). 
Subunits a-4 and a-6 are the least abundant GABAA subunits in the brain under normal 
circumstances; but under conditions of prolonged stress, chronic alcohol or BDZ use, or 
after chronic progesterone/allopregnanolone exposure, a-4 and a-6 appear to come 
online in greater than normal numbers (Foley, et al. 2003; Gulinello and Smith, 2003; 
Poromaa, et al. 2003). The presence of these subunits makes GABAA receptors 
completely insensitive to the sedative and anxiolytic properties of BDZ (Gulinello,
Orman and Smith, 2003) and in fact their presence is considered anxiogenic in most 
animal models (Foley et al. 2003; Gulinello, et al. 2003). In human alcohol withdrawal 
(supported primarily by animal research), researchers speculate that the increased 
presence of a-4 and a-6, mediate many of the anxiety/irritability related symptomology 
(Hsu and Smith, 2003: Smith, 2001; Smith, et al. 1998). Animal studies with pregnant or 
pseudo pregnant rats also show an increased presence of the a-4 and a-6 subunits during 
the late phase of pregnancy and immediately following parturition, suggesting the 
possibility that withdrawal from chronic progesterone elicits most of the mood/anxiety 
behaviors associated with the immediate postpartum period (Gulinello and Smith, 2003; 
Smith, 2001).
If GABAA receptor subunit composition mediates the mood symptoms associated 
with chronic exposure/withdrawal to progesterone, might it also mediate the 
neurocognitive changes anecdotally reported by pregnant and postpartum women? There 
is evidence to suggest that it does both because of its own conformational changes and
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because of the influence these changes exert on other systems, particularly the 
glutaminergic and dopaminergic systems.
From the BDZ animal research, we know that physiological tolerance to the drug 
involves stages o f GABAergic receptor change, which upon withdrawal profoundly 
influences cortical and hippocampal NMDA and a-amino-3-hydroxy-5-methyl-4- 
isoazole propionic acid (AMPA) density (Izzo, et al. 2000). Tolerance to BDZ involves 
the gradual change in GABAA receptor conformation and binding preferences, beginning 
with the uncoupling of subunits associated with sedation and followed by the loss of 
anticonvulsant and anxiolytic subunits (Izzo, et al. 2000). Concurrently, glutaminergic 
transmission is enhanced and AMP A receptor density is increased (Izzo, et al. 2000). 
Upon withdrawal, researchers believe that behavioral^ signs of dependence emerge as the 
changes in GABAergic function rhediates changes in glutaminergic transmission, 
increasing glutamate levels in the frontal cortex, occipital cortex and hippocampus (Izzo,
2000). Interestingly, the behavioral changes do not emerge in full until 96 hours after 
withdrawal from the drug. Researchers speculate that while the changes in GABAergic 
function mediate tolerance to the drug, the changes in glutaminergic function elicit the 
signs of dependence.
In a human study measuring BDZ receptor density using single photon emission 
tomography in nine subjects over the course of a 24-day per/oral administration of 
2mg/day alprazolom, researchers found sedation and deficits in delayed recall were 
present at 16% receptor occupation (Fujita, et al. 1998). From days 3-10 of 
administration, receptor occupancy dropped to 10%, as did reports of sedation and
* The behavioral changes are measured as decreased percentage o f  open-arm entries in the elevated plus 
maze which is presumed to indicate withdrawal induced anxiety (Izzo, 2000).
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deficits in delayed recall. Receptor occupancy normalized at day 17, as did the sedative 
effects of the drug. However, the deficits in delayed recall did not resolve until day 24 
(Fujita, et al. 1998). This is interesting because it suggests that even after physiological 
tolerance occurs (as measured by receptor occupancy), it still takes several days for 
memory deficits to resolve. It also suggests that GABAA receptor density may not be the 
ideal method for measuring drug tolerance/dependence, especially when one considers 
the research discussed above, linking GABAA subunit composition to receptor binding 
properties.
Nonetheless this research does offer some insight into the time course of BDZ 
dependence and tolerance, which should to some degree be similar to that of 
progesterone. However, unlike the research models put forth thus far where a single dose 
is administered at constant intervals over a relatively short period of time, pregnaney 
hormones rise sharply and continuously throughout the term making the degree of 
physiological change likely to be associated with this hormone more akin to those of a 
ehronic drug user and the withdrawal period just as severe. Thus, it is surprising that so 
little data exist linking hormone changes to mental and emotional well-being, particularly 
in pregnancy where the change of circulating hormone levels is so radical.
DHEA and DHEAS
DHEA and its sulfated ester DHEAS have garnered considerable attention in 
recent years for their role in a variety of psychological and physiological functions, 
including mood, memory, immune function and blood-sugar regulation. DHEA is 
synthesized in the adrenals and is a parent precursor for the estradiol, estrone and 
testosterone synthesized in peripheral tissues. DHEA is also considered a neurosteroid.
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thought to be synthesized in the CNS; but as of yet no receptors have been identified 
(Compagnone and Mellon, 1998). Though not a lot is known about DHEA, researchers 
have found some striking connections between emotional well-being, particularly in 
women, and declining DHEA levels in the elderly (Berr, LaFont, Deburie, Dartigues and 
Baulieu, 1996; Wolkowitz, et al. 1997;). DHEA replacement therapy not only returned 
DHEAS and androgen levels to normal but also improved mood and fatigue in patients 
with Addison’s disease (Hunt, et al. 2000). Buckwalter et al. (1999), found DHEA to be 
eonsistently correlated with better mood during pregnancy and to better visuospatial 
performance and with fewer perseverative errors.
DHEAS, the sulfated ester of DHEA, is the most abundant steroid hormone in 
human circulation (Hammer, et al. 2005). During fetal development, the fetal adrenal 
produces vast amounts of DHEAS which is readily converted to DHEA and then to other 
hormones such as testosterone and estradiol. Upon delivery, DHEAS production slows 
and continues to decline until puberty where again adolescent adrenals produce large 
quantities of this hormone. DHEAS levels peak between the ages of 20-30 and then 
decline to as low as 70-80% of those levels by age 70 (Rainey, Carr, Sasano, Suzuki, and 
Mason 2002).
As a sulfate, DHEAS was considered until recently, to be the inactive storage 
reservoir for what was thought to be the biologically active DHEA. Recent research 
suggested that DHEAS is active in its own right. DHEAS is a GABAA antagonist 
(Jacobs, Edelheit, Coleman and Herzog 1999; Roberts, 1999). DHEAS is also capable of 
locally inducing tyrosine hydroxylase in the adrenal medulla and has been shown to 
potentiate norepinephrine release in rat hippocampal cells via NMDA evoked potentials
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(Charalampopoulos, et al. 2005). DHEAS mediated events are thought to occur via 
membrane receptors rather than nuclear receptors because of the rapidity with which 
activity occurs (Charalampopoulos, et al. 2005). Given the potential antagonism by 
DHEAS on the GABAA receptor, combined with the conformational changes of the 
receptor after chronic progesterone exposure, it is possible that together these hormones 
mediate many of the negative mood symptoms associated with postpartum depression. 
Testosterone
Testosterone excess causes a number of recognizable physiological disorders such 
as hirsutism, alopecia and acne and together with other androgens often marks 
pathological adrenal hyperactivity (Carminas and Lobo, (2001). Anabolic steroid use 
upregulates testosterone levels in both men and women with concurrent physiological 
and psychological symptoms. Typical behavioral changes linked to anabolic steroid use 
and hyper-elevated testosterone levels include depression and insomnia, psychosis, 
paranoia, mania, delirium and suicidal or homicidal ideation or behavior (Trenton and 
Currier, 2005). Recent research suggests that anabolic steroid use dimorphically 
downregulates GABAA activity in the female, but not the male, rat medial preoptic 
nucleus. Researchers found that chronically elevated testosterone reduces mRNA 
production of the adrenergic a l and a 2 receptor subunits (Penatti, Porter, Jones and 
Henderson 2005). Other research suggests the testosterone increased myométrial 
relaxation more potently than progesterone in both pregnant and non-pregnant human 
uterine tissue (Persquia, Navarrate, Jasso-Kamel and Montano 2005). Finally, 
Buckwalter et al. (1999) found that elevated postpartal testosterone levels corresponded 
with several domains of negative mood while Hohlagschanddtner, Husslein, Klier and
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Ulm (2001) showed strong negative correlations between testosterone and postpartal 
negative mood.
Summary
As is presented in the following section, much of the research on pregnancy, 
mood and cognition is potentially hampered by an incomplete understanding of hormone 
synthesis, metabolism and the regions of the brain most affected by the reproductive 
hormones. Without a strong theoretical foundation guiding the choice of instrument, 
detecting change is much more difficult. Hence the measures chosen not only vary widely 
from study to study, which is a problem in and of itself, but they may not be capable of 
detecting what are likely to be subtle changes in behavior elicited from a specific pattern 
of neuromodulation. Furthermore, most projects do not measure hormones at all and 
those that do use plasma or serum to measure bound, inactive hormone which is arguably 
not as sensitive a measure as the unbound biologically active component of the hormone. 
Listed below is a fairly exhaustive review of studies exploring the relationship between 
hormones and mood and hormones and cognition in pregnancy and postpartum. Also 
included is research from the premenstrual syndrome (PMS) and the depression 
paradigms.
Hormones and Mood
Prior to adolescence the rates of depression in boys and girls is fairly similar with 
boys showing a slightly higher rate (Angold and Wortham 1993). However, after about 
age 15, the rate of depression in girls and women is nearly two times that of boys and 
men (Angold and Wortham 1993; Spinelli, 1998). Moreover, the increase in
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susceptibility to depression correlates with the hormonal and physical changes associated 
with puberty (Angold and Wortham 1993). The onset of puberty for girls also shows an 
increased risk for cyclic psychosis that seems to correspond with late luteal phase drops 
in progesterone (Amblas, 1993; Stein, Hanukoglu, Blank and Eleizer 1993); the cyclic 
psychosis remits during the menstrual and follicular phases.
Childbirth is another particularly vulnerable time for women. The immediate 
postpartum period is marked by considerable mood lability for at least 80% of all women 
(Spinelli, 1998). Up to 15% of women suffer a bout of full clinical depression following 
parturition and for 40% of those women the depression can last upwards of a year (Panay, 
Sands, Studd, 1998). One to two percent of pregnancies result in maternal hospitalization 
as a result of postpartum psychosis (Spinelli, 1998). Statistics show that during the 
postpartum period, women are some 20 times more likely to develop psychosis than at 
any other time. With the increased risk of psychosis, the risk of suicide increases 70-fold 
during the first year postpartum (Sharma, 2003). Furthermore, 72% of all cases of 
postpartum psychosis occur within the first 10 days after delivery (Klompenhouwer and 
van Hulst 1991). Given the exponential increase and preeipitous decrease of hormones 
during pregnancy and after delivery, one would assume a strong correlation between 
hormones and mood existed, but it does not. To date, there has been no clear and 
consistent link shown between pregnancy hormones and postpartum mood lability. The 
lack of evidence is likely due to a number of factors, but what stands out most, is the lack 
of theory driven testing. Questions such as “which areas of the brain are most likely 
affected by each hormone?” and “what are the consequent behaviors?” are rarely asked. 
Even questions about when to measure the hormones are not asked. For example, in the
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premenstrual syndrome research where hormones levels have not been consistently 
correlated with mood disruptions, even though measures of affect and mood show 
significant symptom exacerbation premenstrually (Redei and Freeman 1994), hormones 
are typically measured at the peak of either the follicular or luteal phases and again at 
menstruation; this presumably is to show the largest change from one phase to the next. 
However, one group of researchers measured throughout the cycle and found that women 
with PMS showed significantly higher levels of progesterone in the late follicular phase 
(when estrogen levels are typically very high and progesterone is generally low) and 
early luteal phase than did controls, preceding symptoms a full 5-7 days (Redei and 
Freeman, 1994). It is possible that there is a similar pattern waiting to be discovered in 
pregnancy research.
Following parturition, women experience significant changes in hormone levels 
and statistics show that up to 80% of all women experience mood lability (Spinelli,
1998), but research has thus far failed to connect the change in hormone levels to the 
change moods. According to a recent meta-analysis and subsequent literature reviews, 
only two studies in 30 plus years showed a significant association between hormones and 
mood and supported the hypothesis that hormone changes underlie mood changes 
(Granger and Underwood, 2001; Harris et al. 1994, Nott, et al. 1976). Other studies 
suggest the possibility of a link, but because of differences in methodology and direction 
as well as small sample sizes, most fail to reach significance (Granger and Underwood,
2001). The two studies reaching significance are reviewed below as are the few others 
reporting trend between hormones and mood.
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In 1976, Nott and associates measured ovarian hormones in 27 primiparous and 
multiparous women via blood 3 times at weekly intervals from 2-6 weeks before 
delivery, the day of delivery, on alternate days for the first week after delivery and every 
3rd -5th day for 5-10 weeks thereafter. They compared hormonal measures with several 
measures of mood over a period of several weeks. The results indicated that higher pre­
delivery estrogen was correlated with increased irritability (r = .36, p < .05) and lower 
post-delivery estrogen was correlated with increased reports of sleep disturbance (r =.43, 
p<.05). The magnitude of change from pre-delivery progesterone to post-delivery 
progesterone correlated with depression at 10 days postpartum (r = .35, p < .05) but was 
negatively correlated with postnatal sleep disturbances (r = .49, p <.05). It would have 
been interesting to see the pattern of pre- and post-delivery hormones in relation to the 
various measures of mood, but these data were not provided.
The Cardiff study, by Harris et al. (1994) is by far the most ambitious study to 
date taking a total of 9654 salivary assays of cortisol and progesterone from 120 women 
over a period from two weeks before delivery up to four weeks after delivery. Harris and 
colleagues (1994) showed a significant relationship in the magnitude of change between 
antenatal and postnatal progesterone and depression scores as measured with a number of 
scales: the Edinburgh Postnatal Depression Scale and the Stein Scale for Maternity Blues 
and the Beck Depression Inventory. They were unable to find any relationship between 
cortisol and mood. Although this was a very good study, they measured only depression 
and not the other aspects of mood, mental state or cognitive functioning that could be 
presumably affected by the rise and fall of progesterone. Recall from the BDZ research 
that irritability and anxiety are the most prevalent symptoms appearing during
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withdrawal. If we look at the constellation of symptoms associated with postpartum 
mood changes, we see that anxiety and irritability may underlie many of the symptoms 
(see Table 2) particularly in the more severe cases. By focusing on depression, most 
studies potentially limit their results.
Other studies, including O'Hara, Schechle, Lewis and Wright, (1991) and Metz et 
al. (1983), measured plasma progesterone and estrogen concentrations at various times 
both pre- and postnatally. O'Hara and colleagues found a signifieant positive relationship 
between antepartum free and total estriol levels and postpartum blues. Metz, et al. found 
no direct correlation between ovarian hormones and mood, but did show that the 
magnitude of fall in hormones was positively correlated with a2-adrenoreceptor binding 
capacity, which was in turn correlated with measures of postpartum mood lability. Kuevi, 
et al. (1983) reported a trend towards higher FSH and lower estrogen and progesterone 
levels in women with the blues, particularly those women who showed a consistent state 
of'blues' versus women who experienced brief periods of mood lability. Finally, Gard, 
Handley, Parsons and Waldron, (1986) reported a higher incidence of postpartum blues 
with the birth of a male child and/or a previous history of gynecological disorder, either 
of which could indicate endocrine involvement. Notice that each of these studies 
implicates hormone involvement in postpartum mood lability at least indirectly; this is 
important because each research group utilized entirely different measures and, in fact, 
had different definitions of postpartum mood disturbances.
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Hormones and Cognition
If there is a relationship, however tenuous at this point, between hormones and 
mood, might hormones mediate cognitive function? Some research suggests that they do. 
Phillips and Sherwin (1992) report variations in memory function across the menstrual 
cycle, with visual memory significantly impaired during the menstrual phase as compared 
to the luteal phase, and paired-associate learning correlated with high estradiol during the 
luteal phase. Interestingly, testosterone was negatively correlated with paragraph recall. 
Hampson (1990) found that articulatory and fine motor skills improved during the late 
follicular phase, while spatial tasks faltered compared to the scores during menstrual 
phase.
Thompson, et al. (2000) found that estrogen fluctuation mediates various 
measures of cognitive function for women with and without psychosis. When estrogen 
levels were at their highest (during the second peak in the luteal phase), women with 
psychosis performed significantly worse than controls on Purdue pegboard. Both groups 
showed significantly better scores on spatial tests when both estrogen and progesterone 
were low (menstruation) compared to when the hormones were high and performance on 
Trails A was better when estrogen was low. These results suggest that estrogen adversely 
affects spatial skills. Interestingly, the women with psychosis not only had much higher 
incidence of endocrine problems, obviously some associated with the neuroleptics but 
also reported histories of menstrual dysfunction prior to their first episodes. Moreover, 
these women showed abnormally elevated progesterone levels during the follicular phase 
compared to controls, followed by lower than normal progesterone in the luteal phase 
(Thompson, et al. 2000). This follows the pattern of mood disturbance reported by Harris,
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et al. (1994) linking magnitude of change in progesterone to increase in mood 
disturbanee. It also suggests some common link between higher than normal levels of 
progesterone in the follicular phase and PMS as reported by Redei and Freedman (1995).
Some studies have suggested changes in cognitive function both during and after 
pregnancy. Jarrahi-Zadeh et al. (1969) measured multiple subjective and objective 
cognitive and affective modalities in 86 women at various times during their last 
trimester and on the 3rd day postpartum. These data were compared to data obtained 
from a group of 21 controls. The cognitive measures included Trails B and the Porteus 
Maze test. Scoring for both tasks reflected only total time required to eomplete the task 
and did not inelude errors. The results showed a signifieant difference between pregnant 
and non-pregnant controls and between postpartum and non-pregnant controls in Porteus 
Maze completion times. The authors reported increased subjective complaints with 
concentration at both time points and suggested that the combined test results and 
subjective data indicated that pregnant and postpartum women showed difficulties in 
concentration and planning. Difficulties in concentration and planning would be 
consistent with elevated progesterone and estrogen, as would motor slowing. Another 
possible explanation would be that spatial skills appear to falter with high levels of both 
hormones but improved when levels wane, as was suggested by Hampson (1990).
Brindle, et al. (1991) found that pregnant women showed significant deficits in 
implicit but not explicit memory at 36 weeks compared to controls and reported a 
significantly higher subjective rating of impairment (59% vs. 11%). In 1993, Sharp and 
colleagues found similar results reporting that pregnant women were signifieantly 
impaired in incidental learning tasks, in word list recall, and word-stem completion when
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compared to controls. These findings are particularly interesting given recent research in 
the dissociation between explicit and implicit memory systems. Explicit memory, the 
conscious recall of information, appears to involve both frontal and temporal activation, 
particularly the cingulate gyrus and hippocampal formation; implicit memory or 
unconscious recall of information involves activation of the particular sensory area called 
into action during the task (Fleishman, Vaidya, Lange and Gabrieli 1997). For example, 
retrieval of procedural memory involves activation of the basal ganglia and the 
cerebellum, while visually presented implicit recall tasks involve activation of the medial 
dorsal occipital/temporal regions (visual association areas-Brodmann's areas (BA) 17, 18, 
19) (Samuelsson, Bogges and Karlsson 2000). Most of the neurocognitive tests for 
implicit memory are visual in nature and hence should activate BA 17, 18, 19.
Individuals with lesions to the BA 17,18, 19, show severe deficits in implicit memory as 
tested by visual priming tasks, but not in auditory or procedural tasks (Samuelsson, et al. 
2000). Normal participants performing the visual priming tasks while being measured by 
fMRI, however, show diminished activation in those areas as eompared to when 
performing explicit memory tasks perhaps indicating that the region is part of a more 
extensive loop that may be regulated by other regions, particularly the frontal cortex 
(Buckner, et al. 1995). Another interesting finding in the Buckner et al. (1995) study was 
that explicit and implicit recall tasks showed left and right PFC activation, right 
hippocampal activation and no left temporal activation. Recall from the BDZ research 
discussed previously (Izzo, et al. 2000) that tolerance to BDZ is measured by withdrawal 
characteristics and one of the more prominent characteristics was an increased 
transmission of glutamate and concurrent increased AMPA receptor density in the several
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regions of the brain including the prefrontal cortex (PFC), hippocampus and the occipital 
lobe. It is possible that glutamate changes in the occipital region modulated by 
progesterone mediate the implicit memory deficit observed in pregnant women either 
directly via glutamate/AMP A or indirectly via changes to upstream neural pathways in 
the PFC. In either case, both Brindle, et al. and Sharp, et al. provide a clue to possible 
cognitive changes during pregnancy. Sharp, et al. ,Jarrehi-Zaddeh et al. and Brindle et al. 
also collected subjective reports of memory which revealed that 81% of the pregnant 
women rated their memory as impaired compared to 16% of the control subjects. This 
indicates that the women were aware of the changes in memory.
Eidelmen, Hoffman and Kaitz (1993), using a between subjects design, looked at 
memory deficits in 100 postpartum (days 1-3) women using the Weschler Logical 
Memory Test and the Weschler Visual Reproduction Test. They found that though 
significant memory deficits on both scales appeared on day one they resolved by day 
three. Interestingly, they tested fathers and found that they too showed impaired 
performance on the logical memory test but not on the visual reproduction test on day 
one, perhaps indicating that stress, exhaustion and all of the other overwhelming 
emotions immediately after delivery have more to do with memory function than 
anything else.
Recently de Groot, Adam and Homstra (2003) reported deficits in selective 
attention at 36 weeks that had resolved by 32 weeks postpartum. Researchers used what a 
spatial finger precuing task wherein subjects were given cues regarding the spatial 
location of an upcoming target stimulus. Researchers believe that this task measures 
selective attention, which they define as the ability to identify, discriminate and select a
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target. It also measures motor speed. The precuing task, like other priming tasks, should 
improve performance over baseline measures. However, pregnant women performed 
significantly worse than did controls and showed little to no priming effect. Although de 
Groot, et al. suggest that this task measures selective attention, its similarity to standard 
measures of implicit memory is overwhelming. As such, one could suggest that the 
deficit measured by these researchers involves the procedural implicit memory system 
and the activation or inactivation of basal ganglia and cerebellar regions. It is also 
possible that during pregnancy the sedative effects of progesterone slow motor 
responsiveness and thereby prevent women from improving on this particular task.
Dysregulation in these areas would be expected given the pattern of G ABA and 
NMD A/glutamate activation mediated hy progesterone. Recall from Bixo, et al. (1997) 
that the sedation-inducing metabolites of progesterone (allopregnanolone and 5a-DHP) 
are heavily concentrated in the cerebellum and substantia nigra as well as in other 
regions. Recall also that these metabolites modulate NMDA receptor density, glutamate 
and DA transmission in the basal ganglia (Cabrera, et al. 2002; Cabrera and Navarro 
1996; McEwen, 1998). Given the exponential increase in progesterone during pregnancy 
one would expect deficits in these areas, and would also expect them to dissipate by 32 
weeks postpartum.
Finally, Crawley, Dennison and Carter (2003) found no differences between 
pregnant and non-pregnant controls in a variety of cognitive modalities tested during the 
second and third trimesters as well as at six weeks and one year postpartum. They did 
find that a significant portion of the women tested reported a higher incidence of 
perceived memory deficit during the third trimester.
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Thus far none of the studies discussed herein collected hormone data. To date 
there are only a few studies that have collected hormone data at all and even fewer that 
have correlated those data with cognition. More research appears to have heen done in 
the PMS paradigm than in the pregnancy/postpartum paradigm. In the pregnancy 
postpartum arena, an extended search on Psychlnfo and Medline revealed only one study 
in the last 30 years that measured perinatal hormones, cognition and mood, Buckwalter et 
al. (1999).
Buckwalter and associates (1999) measured cognitive function, mood and 
hormone levels in 19 primiparous women at approximately 36 weeks of pregnancy and 2- 
4 weeks after delivery. Unlike all previous studies, they utilized a full standard hattery of 
neuropsychiatrie assessment tools that included a range of neurocognitive and psychiatric 
measures. They also took two blood samples and used RIA to measure estradiol, 
testosterone, progesterone and DHEA. Researchers asked three questions: 1) were there 
changes in cognition during pregnancy? 2) were there changes in mood during 
pregnancy? and 3) were hormones associated with cognition or mood during and after 
pregnancy? They found that indeed there were changes in both mood and cognition 
during pregnancy and that these changes persisted at least through four weeks 
postpartum.
Regarding changes in cognition during pregnancy, Buckwalter, et al. found that 
pregnant women performed significantly worse on several aspects of the California 
Verbal Learning Test (CVLT) compared to normative data for women of similar age and 
education. They were particularly impaired on trials 1 and 5, scoring in only the 6th and 
5th percentiles respectively; they also showed significantly lower learning slopes ranking
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only in the 32nd percentile. Authors of the CVLT suggest that low scores on trial 1 occur 
often in individuals who are depressed and/or anxious but resolve by trial five and show 
normal learning across the five trials. Buckwalter et al. (1999) showed that indeed 
pregnant women were impaired on trial 1, but they were also impaired on trial five as 
well as on trials 1-5 combined and showed a diminished learning curve compared to 
norms. Dellis et al. (2000) suggest that impairment in trial 1, barring depression or 
anxiety related performance (which may he a factor in pregnant/postpartum women), 
indicates poor auditory attention span. Since different neurological deficits show discrete 
patterns of reduced learning across the trials, a reduction in the learning curve could 
indicate a number of neurological impairments; but since Buckwalter et al. did not list the 
scores from trials 2-4 it is impossible to interpret these results. According to Buckwalter, 
et al. subjects performed significantly worse in both the short and long free recall tasks 
(17th percentile for both) indicating potential problems in either retention and/or 
attention. They also performed more poorly on short and long cued recall tasks (21st and 
16th percentiles, respectively) and had a higher than normal number of intrusions. Dellis 
et al. suggest that impaired performance across all tasks indicates problems with retention 
and that an elevated number of intrusions indicate problems with either confabulation or 
disinhibition, the sum total of which appears to indicate some sort of left frontal and 
temporal dysfunction (Dellis, et al. 2000).
In addition to the deficits listed above, the pregnant women showed significant 
impairment on Trails A, 2Ist percentile, but not Trails B. They also performed more 
poorly on Trails B , the Stroop test, the Boston naming test and Digit Span Backward 
when pregnant, but failed to reach statistical significance (46th, 47th, 16th percentiles
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respectively). These results suggest a fairly diffuse pattern of left hemisphere impairment 
that the researchers were unable to elucidate. This pattern of left hemisphere impairment 
may be significant or it may indicate that right hemisphere activity has yet to be 
consistently measured. What these results do not show is a glaring deficit in any one 
cognitive domain, which is perhaps why so many researchers fail to attribute the 
cognitive changes associated with pregnancy to pregnancy related hormones.
Buckwalter, et al. (1999) also measured affective changes associated with 
pregnancy and postpartum. Of the 19 women in the study, 15 completed the Symptom 
Checklist-90 (SCL-90), which measures clusters of symptoms relating to common 
psychiatric profiles including somatization, obsessive-compulsive behavior, interpersonal 
sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation and 
psychoticism and the Profile of Mood States (POMS), which measures five clusters of 
symptoms, depression, anxiety, confusion, fatigue and vigor. Unfortunately they found 
no consistent association between hormones and cognition, or hormones and mood or 
mood and cognition. But they did find some interesting trends, particularly with DHEA 
and cortisol. During pregnancy DHEA was associated with higher scores on the 
Judgment of Line task (r = .65, p -  .006) and cortisol was significantly correlated with 
fewer perseverative errors^ on the CVLT (r = -.57, p = .01). Neither estradiol nor 
progesterone was correlated with any cognitive measure. After pregnancy, both DHEA 
and cortisol were associated with better performance on a number of measures.
’ Perseverative errors is a misnomer in CLVT nomenclature. Perseveration typically refers to failure to shift 
set. In the CVLT perseverative errors refer to the number o f  repeated words in the list. In the CVLT-Il, test 
designers have reclassified perseverative errors to repetition errors (Delis, Kramer, Kaplan, Ober, 2000).
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DHEA was correlated with better mood during pregnancy but showed a more 
inconsistent pattern after delivery. During pregnancy, DHEA was correlated with lower 
scores on the Beck Depression Inventory as well as on several of the dimensions of the 
SCL-90 and POMS. Testosterone was associated with negative mood symptoms after 
delivery but not during pregnancy. The change of hormone levels from pregnancy to 
postpartum also showed correlations to mood. The change in estradiol was significantly 
correlated to a decrease in phobic anxiety, confusion, fatigue scores on the SCL-90 and 
POMS measures.
The DHEA findings are interesting, particularly when one considers that DHEA 
levels are inversely related to progesterone levels so that when progesterone is high 
DHEA is low (Compangnone and Mellon, 1998). According to Buckwalter et al. (1999) 
DHEA was associated with better mood during pregnancy, since they did not mention 
whether or not progesterone was especially low in those women who reported better 
mood states, we can speculate that it was in as far as increased progesterone was 
associated with negative mood during pregnancy. Moreover, since progesterone levels 
are greatly diminished after pregnancy, one might speculate that DHEA levels should be 
increased to maintain hormonal equilibrium. Researchers reported that diminished DHEA 
levels postpartum correlated with depressed mood, which is consistent with the 
physiological relationship between the two hormones. If both hormones were diminished 
postpartum, as these data appear to suggest, then the feedback loop between the two 
could be impaired and may suggest a physiological marker linked to postpartum 
psychopathology.
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These results are important because they confirm that steroid hormones are linked 
to changes in both mood and cognition. But like almost all other studies on this topic, 
they do not appear to show a clear pattern of behavior associated with pregnancy related 
hormones. Some hormones are correlated with some mood changes but not consistently, 
and no hormones were correlated with the cognitive deficits. This is where understanding 
the synthesis and metabolism as well as the neurotransmitter systems modulated by these 
hormones comes into play. For example, the relationship between DHEA and 
progesterone as well as between testosterone and estradiol are often overlooked, but are 
exactly the relationships that may yield the most important factors predisposing some 
women to postpartum mental illness.
Recall from the earlier discussion, that each of the hormones modulates each of 
the neurotransmitter systems to some degree or another. Also recall that individually 
estrogen is generally eonsidered excitatory while progesterone is considered highly 
sedative; together, however, they work synergistically. Progesterone potentiates the 
actions of estrogen (particularly in the area of synaptogenesis) and estrogen primes 
receptors for progesterone (progesterone alone will not initiate synaptogenesis). Recall 
also that 1) progesterone is the precursor for many of the other hormones 2) progesterone 
produces very active metabolites and 3) progesterone is inversely related to DHEA levels 
and probably, though this is not reported related to estrogen, testosterone and other 
downstream hormones. Since the presence or absence of progesterone modulates effects 
of the other hormones on individual neurotransmitter systems, perhaps what needs to be 
measured is the relationship among progesterone, estrogen, testosterone and behavior.
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Recall also from Bixo, et al. (1997) and the several animal studies cited earlier 
(Cabrera, et al. 2002;Fink, et al. 1998; Keefe, 2002; McEwen, et al. 2001; McEwen, et 
al. 1997) that progesterone is heavily concentrated in the several regions of the brain 
including the amygdala, cerebellum, frontal cortex, cingulate gyrus, substantia nigra, 
hippocampus, the thalamus and hypothalamus. Given its relative dispersion, one would 
expect a fairly diffuse pattern of change that affects not only mood state, but a variety of 
cognitive behavioral functions in a somewhat more pervasive than gross manner. From 
all of the studies thus far, this is exactly what we have: a relatively pervasive diminution 
of left hemisphere function. It is likely that right hemisphere function is also affected but 
as of yet this has not been tested.
To fully measure the pattern of changes associated with perinatal hormones 
several factors need to be addressed. First, the neuropsychiatrie measures should focus on 
the modalities most affected by progesterone, but also include measures not hereto 
indicated (right hemisphere) to rule in/out potential impairment in other regions.
Secondly, the relationship between progesterone and the other ovarian hormones should 
be assessed in association with performance on behavioral measures. Thirdly, a topic thus 
far not addressed is the possibility that the relationship between hormones and behavior is 
non-linear thereby preventing linear statistics from delineating the pattern of significance. 
Summary
Given the data presented throughout this document it is clear that pregnancy 
hormones modulate virtually every neurotransmitter system within the central nervous 
system. What should be particularly clear is the role that progesterone plays in 
neuromodulation. Progesterone is a precursor to many steroid hormones, effectively
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modulates numerous neurotransmitter systems on its own, and attenuates the actions of 
other hormones; likewise other hormones, particularly estrogen, play a vital role in 
progesterone's efficacy.
However complex the relationship is between the various hormones, each is to 
some degree or another dependent upon progesterone. Given this, it seems logical to base 
the predictions about the effects of steroid hormones on behavior on progesterone's 
pattern of distribution and inherent properties. Thus, the sedative properties of 
progesterone should produce changes in concentration, attention, motor and/or cognitive 
slowing. Its anxiolytic properties should reduce anxiety during pregnancy but increase 
anxiety toward term and after delivery during the withdrawal phase. Its affinity to 
GABAA receptors in the hippocampus should affect learning and memory (McEwen, 
1998), especially where processing speed is involved, while its presence in the raphe 
nucleus might alter arousal and excitability (Klink, et al. 2002; Oades, 1978). The 
increase in circulating DA during pregnancy, particularly in the nucleus accumbens, 
should increase motivational or pleasure seeking activities as an addictive drug might, but 
the precipitous decline in DA after delivery should cause a bevy of withdrawal type 
symptoms, including increased anxiety. Since one of the major projection pathways from 
the nucleus accumbens is to the frontal cortex, the decline in both G ABA and DA should 
have adverse effects on planning, organization and executive function as well as affect 
regulation particularly with regard to social judgment and motivation via their 
connections with the amygdala and other limbic structures.
To the extent that the exhibited behaviors differ from what is expected, based 
upon the primacy of progesterone, one can surmise possible dysregulation at other
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junctions within the pathway. For example, if ratio of progesterone to estrone/estradiol is 
disturbed it is possible that behaviors exhibited by the subject would be more consistent 
with elevated estrone/estradiol than with diminished progesterone; sinee neither the 
appropriate ratios of one hormone to the next nor the associated behaviors therewith have 
been identified, this is only speculation.
Hypotheses and Predictions 
Given the complexity of steroid endocrinology and the lack of research in this 
area, the current predictions and hypothesis are necessarily broad. This is a preliminary 
study that is driven by the physiology of a system that is not entirely understood. With 
this in mind, it is predicted that during pregnancy the subjects will experience general 
cognitive decline in each of the areas tested as compared to age- and education-matched 
norms. At time two, ten days after delivery, the deficits will remain but may have 
improved slightly. The magnitude of change in progesterone from antenatal to postnatal 
will correlate with measures of mood; however, what the pattern will be is as of yet 
unclear.
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CHAPTER 3
METHODS
Participants
Inclusionary Criteria
Participants were healthy, primigravid women, ages 21-40 without histories of 
drug/alcohol abuse or neurological disorder. It was originally intended to exclude women 
taking medication. After discovering the high number of women taking a wide variety of 
. medications during pregnancy, this criterion was modified to exclude only psychotropic 
medications and/or those medications that might interfere with either hormone levels or 
performance on psychological tests. All medications were reviewed before the participant 
was admitted into the study. This study was approved by the University of Nevada, Las 
Vegas Office for the Protection of Human Subjects prior to initiation (Appendix A). 
Recruitment
Participants were recruited primarily from presentations given at area childbirth 
education classes. Other recruitment means were employed such as press releases, 
distribution of flyers to area physicians and around campus, booths at baby fairs and 
seminars on postpartum depression, but fully 98% of all participants were recruited from 
presentations given at childbirth classes. Presentations outlined the study’s purpose, 
design and exclusionary/inclusionary criteria. Following each presentation, those 
interested were asked to sign-up for a follow-up call where questions were answered and
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enrollment appointments made. Presentations were given at multiple hospitals on a 
weekly basis for approximately 10 months. Childbirth education classes ranged in size 
from two or three to 20 participants and approximately a quarter of women per class were 
qualified and/or interested in the study.
Over the course of 10 months, approximately 75 women expressed initial interest 
in the study. Of the 75 who expressed interest, 38 were enrolled in the study. The thirty- 
seven women who expressed interest and subsequently did not enroll were either 
disqualified for health or medication issues, multiparity, or upon follow-up lost interest. 
An unknown but seemingly high number of women expressed verbal interest in the study 
but self-excluded because of psychotropic medications.
Descriptives and Demographics
Of the thirty-eight women enrolled in the study, 32 were tested at time one (Tl) 
and 28 of the 32 were tested at time two (T2). Six women who enrolled into the study 
gave birth prior to the first testing session. Two of those six were in labor on the day of 
the first testing session. Four women tested at Tl failed to complete the T2 postpartum 
testing. Of those women who failed to complete postpartum testing, one woman missed 
her second appointment, one chose not to complete the study due to postpartum stress, 
one participant had a medical emergency related to childbirth, and the remaining 
participant failed to return calls for postpartum scheduling. Of the 32 who entered the 
study, Tl hormone data was lost by FedEx for one participant. Five of the women 
admitted into the study were taking medications. Two were taking allergy medications, 
two were taking antacid type medications and one was prescribed a blood thinner during 
the last weeks of pregnancy.
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All of the 28 women who completed the study gave birth to healthy babies. Out of 
the 32 women who entered the study, 16 had girls and 16 had boys. Twenty-four of the 
women gave birth vaginally and eight had cesareans. Labor was induced in nine of the 
women who delivered vaginally. Of the cesareans none were scheduled in advance and 
all became necessary either because of a medical emergency or because labor had stalled. 
The average length of gestation was 275 days with a range of 260-289 days.
All of the women who enrolled in this study were employed full-time in a range 
of positions through the majority of their pregnancies. As a whole the women were 
highly educated. They averaged 15.73 years of education with a range of 12-19 years.
Full scale IQ as estimated using the Barona Index and confirmed by the National Adult 
Reading Test (NART) was 111.98, with a range from 101 to 115. The group was 
predominately Caucasian, (n =29), one African American woman was tested at T l, but 
subsequently dropped out. Two Hispanic women entered the study and were tested at Tl, 
but only one completed the study.
Enrollment and Testing
Participants expressing interest in the study were contacted by phone and 
enrollment appointments were set. Enrollment appointments took place in the 
participants’ home or office. At the enrollment, participants were given and signed the 
informed consent (appendix B). Demographic information was collected (Appendix C) 
and inclusionary evaluations were made. Upon qualification for the study, the NART was 
administered, instructions for specimen collection were given (Appendix D) and Tl 
appointments were set. Participants were enrolled from 32 weeks of pregnancy until 36 
weeks of pregnancy.
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The first testing session took place at 37 weeks of pregnancy +/- 2 days. The 
second testing session took place within the first 10 days postpartum for all hut three 
participants, who were tested on day 11 or 12. The average postpartum testing session 
occurred on day eight with the earliest occurring on day four. Both pre and postpartum 
testing sessions were at the participant’s home.
Specimen collection was tightly controlled. The morning of each testing session, 
participants were instructed to spit into a vial upon arising, at 9 AM, before eating 
drinking or brushing teeth. At the postpartum testing session they were also instructed to 
not spit within two hours of breastfeeding. At Tl the mean saliva collection time was 
8:46 AM, the median and mode were 9:00 AM. At T2, the mean saliva collection time 
was 8:26 AM, the median was 8:46 AM and the mode was 9:00 AM. All salivary 
samples were picked up at the testing session and mailed via FedEx to All Via Diagnostic 
Lab in Phoenix, AZ for analysis.
The order of testing was also controlled and was as follows for each testing 
session: the Symptom Checklist 90-revised (SCL-90R), the California Verbal Learning 
Test-II (CVLT-II) part one. Paced Auditory Serial Attention Test (PASAT), the CVLT- 
Il-part two, the Rey Complex Figure Test (CFT)- copy, the Finger Tapping Test (FTT), 
the Purdue Pegboard, the Verbal Fluency Test, CFT-recall and the Design Fluency Test.
Breaks were given as requested and when needed to allot for down-time between 
tests. Testing at Tl took approximately one hour and fifteen minutes. Testing at T2 
sometimes took two hours or more in part because of interruptions and the participant’s 
interest in discussing the birth. To compensate for practice effects at T2, alternate test 
forms were administered for the CVLT-II, and the Rey CFT.
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Neurocognitive and Neuropsychiatrie Measures
Intelligence
Intelligence was estimated using two measures the Barona Index and the North 
American Adult Reading Index (NART). The Barona Index provided a quick and reliable 
estimate of general intelligence using basic demographic and educational information 
(Spreen and Strauss, 1991). The NART also provided a quick and reliable estimate of 
intelligence by using a reading test of 50 irregularly spelled words to assess premorbid 
intellectual ability. The NART is considered very reliable and highly correlated with 
other measures of general intellectual ability (Spreen and Straus, 1998).
Mood
Mood will he measured using the SCL-90R. The SCL-90R is a 90 item, self­
administered measure with nine clusters of symptoms relating to common psychiatric 
profiles and a global severity scale to measure average severity of symptoms (Derogatis,
1994). The symptom clusters measured included somatization, obsessive-compulsive 
behavior, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid 
ideation, psyehoticism.
Cognitive Functioning
Neurocognitive functioning was assessed using multiple tools including the 
CVLT-II, PAS AT, Rey CFT, the verbal and spatial fluency tests, the Purdue Pegboard 
test and the finger-tapping test.
The CVLT-II assessed short and long-term memory as well as learning strategy 
and conceptual organization using five trials of 16 words in four conceptual categories 
(Lezak, 1995; Spreen and Straus, 1991). Results are evaluated based upon total recall.
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total errors, short and long delay recall, cued-recall and recall with intrusions (Lezak, 
1995; Spreen and Straus, 1991). Buckwalter et al. (1999) found significant impairment in 
pregnant women both antenatally and postnatally. Activation studies show that the CVLT 
activates the left inferior prefrontal cortex, the left dorsal lateral prefrontal cortex, the 
orbitofrontal cortex and the left hippocampus (Savage, et al. 2001) areas potentially 
affected by steriod hormone changes.
The PASAT was used to assess the rate of information processing, sustained 
attention and vigilance. The PASAT consists of a taped presentation of randomly 
presented numbers. In each trial, the subject is asked to add pairs of numbers together in 
sequence with the second number added to the first, the third number added to the 
second, etc. There are four trials each with increasingly more difficult presentation rates 
(Lezak, 1995; Spreen and Straus, 1991). The PASAT is believed to be especially 
sensitive to subtle changes in attentional abilities. Pregnant women receiving magnesium 
sulfate to slow early labor performed significantly more poorly on the PASAT than when 
not receiving magnesium sulfate (Ghia, et al. 2000). Recall from the Buckwalter et al. 
(1999) study that pregnant women scored well below norms in all five trials of the 
CVLT. Authors of the CVLT-II suggest that such low scores may be attributed to poor 
auditory attention span (Dellis, et al. 2000).
The CFT measured visual spatial and constructional ability as well as visual 
memory, planning, organizational and problem solving (Lezak, 1995; Spreen and Straus, 
1991). Subjects were asked to copy a complex figure and after a delay and without prior 
warning were asked to produce it again from memory. The figure was scored based upon
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accuracy and recall (Spreen and Straus, 1991). Cummings and Trimble (1995) suggest 
that this measure is particularly adept at identifying frontal cortex dysfunction.
The verbal and spatial fluency tests were designed to measure lateralized 
executive functioning. During the verbal fluency task subjects were asked to name as 
many words as they could in a particular category in one minute. They are also asked to 
name animals within a minute. Verbal fluency assesses left frontal cortex functioning. 
For the spatial fluency task subjects were asked to draw multiple novel figures within a 
certain time frame. The spatial fluency test assessed right frontal cortex functioning 
(Cummings and Trimble, 1995). Both tasks are particularly difficult for individuals with 
dorsal lateral prefrontal cortex (DLPFC) injuries; the DLPFC is one pathway that should 
be affected especially hard by progesterone withdrawal both because of its effects on 
G ABA and on NMDA-mediated DA release.
The Purdue Pegboard assessed fine motor dexterity and motor processing speed 
as well as right-left dominance. Subjects were asked to take pegs from a cup and place 
them in the pegboard, first with the dominant hand, then the non-dominant hand, and 
finally with both hands. Each trial takes thirty seconds and is scored by number of pegs 
placed during each time period (Spreen and Straus, 1991).
The finger tapping test measured fine motor speed and right-left dominance. 
Subjects must tap a key with the index finger of each hand as quickly as possible for five 
trials of 10 seconds each. Scores were computed for each hand and a mean for the five 
trials was produced (Spreen and Straus, 1991).
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Factors Determining Assessment Timing and Instrument Choice 
To capture the largest change in hormones, it was decided in the present study to 
test each subject at approximately 37 weeks and within the first ten days postpartum. 
Studies show that hormones continue to rise until immediately before delivery when they 
then begin to decline slowly and decrementally in preparation for delivery (Harris, et al. 
1993). After the fetoplacental unit is delivered, the woman's circulating level of 
hormones decreases rapidly to a level below that of her normal menstrual cycle (Challis 
and Lye, 1998; Harris, et al. 1993). The decreased level of circulating ovarian hormones 
is maintained for as long as the woman breastfeeds; it is not until breastfeeding ceases 
that FSH increases sufficiently to stimulate follicle growth which in turn stimulates 
estradiol and the subsequent LH and progesterone surges required for menstruation 
(Griffin and Ojeda 2000; Kaplan, et al. 2003). Researchers have chosen to assess 
hormone levels and either cognitive or affective factors at a variety of time points 
postpartum, arguing that since hormone levels do not return to normal until breastfeeding 
stops, it doesn't matter when one tests. This is problematic for two reasons. First, 
although hormones may remain unusually low for several months postpartum, neural and 
behavioral adaptation is likely to occur over time thereby diminishing the outcome 
measures. Secondly, studies in postpartum psychosis indicate that over 70% of all 
incidents occur within the first ten days postpartum (Klompenhouwer and van Hulst 
1991). It seems that that if  there were a change in affective regulation and even cognition, 
it would occur sooner rather than later. Given these two facts, it was decided to test both 
at 37 weeks and within the first ten days postpartum. However, because both excessively 
low hormones and excessively high hormones are likely to adversely affect mood and
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cognition, measuring at these times makes capturing differences in behavior between the 
two time points statistically difficult. Additionally, even with the most targeted and 
sensitive instruments, it is not likely that one would be able to distinguish between those 
deficits associated with high hormones versus those associated with low hormones. 
Nonetheless, testing at these time points provided important data regarding the patterns of 
deficit associated with a particular hormonal state that will guide future studies and 
potential test designs.
Testing within the first ten days postpartum presented some logistical difficulties, 
including mothers who were hesitant to leave their newborns to participate in the 
research, particularly since the testing took an extended period of time. To compensate 
for this possibility, all tests chosen were portable and could be performed at the 
participant’s home. In addition, each test was chosen not only because it measured the 
functioning of a particular brain region, but also because each could be performed 
relatively quickly.
Data Analysis
Data analysis looked at two groups of questions. The first group asked: 1) are 
there changes in mood during pregnancy compared to norms? 2) Are there changes in 
mood after pregnancy related to norms? 3) Do these changes correlate with any of the 
hormones measured? 4) Are there changes in mood from Tl to T2? 5) Do mood changes 
eorrelate with any of the cognitive measures? The second group asked: 1) are there 
changes in cognitive functioning during pregnancy compared to norms? 2) Are there 
changes in cognitive function after pregnancy compared to norms? 3) Are there changes
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in cognitive functioning from pregnancy (Tl) to postpartum (T2)? 4) Do these changes 
correlate with any of the hormones measured?
Since there was no control group for this study, z-scores from both the mood and 
cognitive measures were calculated and compared to z-scores from available age and 
education matched norms to give percentile rank.
To compute the relationship between hormones and individual tests, multiple 
correlation matrices were used to correlate each hormone at Tl with each neurocognitive 
test and symptom cluster from the SCL-90 at T l . Likewise each hormone was correlated 
with each neurocognitive and mood test at T2. Changes in hormone levels from Tl to T2 
were correlated with changes in cognition and mood from T1-T2. Additionally, 
pregnancy hormones were correlated with postpartum mood to determine if there are 
early biological markers of postpartum negative mood.
It is acknowledged that the sheer number of analyses being performed increased 
the type 1 error rate and the limited number of participants decreased the power. 
However, this was a preliminary study for which there was little precedent. It was, 
therefore, important to assess a number of areas in order to delineate all possible patterns.
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CHAPTER 4
RESULTS
Results
Statistics
This was a comprehensive study designed to measure the full spectrum of 
cognitive and affective correlates associated with a broad range of reproductive hormones 
during late pregnancy and early postpartum. This necessitated measuring not only a 
thoroughly representative number of cognitive and affective variables but also a full 
complement of reproductive hormones. Measuring multiple hormones is inordinately 
expensive and, thus, limited the number of participants in the present research. The large 
number of cognitive, affective and hormone variables coupled with the small participant 
pool diminished both the sensitivity and reliability of the statistical analyses performed 
and compromised interpretation of the data obtained.
To compensate for reduced statistical power and increased error, researchers 
typically employ statistical corrections such as the Bonferonni method, or they increase 
the reportable alpha level. Insofar as this was an exploratory project meant to guide the 
direction of future research, it was decided not to do either of those procedures; instead 
all statistically significant relationships were reported with the caveat that statistical 
power was limited and the possibility of over-reporting significance existed in the present 
research, as does the possibility of reporting artifactual versus real relationships.
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Nonetheless, the data reported in this study provide a critically important step in 
understanding the relationship amongst hormones, cognition and mood.
This study utilized both between and within factors for analysis. Comparisons 
were made between collected data and published normative data when available, as well 
as between the participants themselves. Given the large data set and number of analyses 
run, the results section was organized first into three broad sections that include the main 
variables within the study, hormones, mood and cognition. Within each section, 
descriptive statistics were given followed by t-tests comparing collected data to published 
data and/or z-scores and percentile scaled scores. This was followed by correlations 
between the individual variables as well as analyses and correlations of change scores.
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Part One: Hormones
Methods
Unlike other studies that typically have measured only one or two hormones, this 
study measured five hormones important to pregnancy. Hormones were measured from 
saliva using the ELISA method. Un-stimulated, morning salivary samples were collected 
according to the protocols outlined previously from each woman at each test time. 
Salivary samples were shipped via FedEx to All Via Diagnostic laboratory in Phoenix,
AZ where they were frozen immediately at -20 degrees Celsius and processed within 24 
hours. The inter-assay coefficient of variation for each hormone was as follows: 
progesterone 2.9%, DHEAS, 3.7%, estrone, 16.25%, estradiol, 3.4%, estriol, 3.6% and 
testosterone, 4.9%. Descriptive data for each hormone obtained during pregnancy and 
postpartum are given in Table 3.
Assessing the faee validity of these results was particularly difficult insofar as 
there are very few published studies with salivary hormone levels in pregnant and 
postpartum women. This was compounded hy the fact that hormone data in general are 
marked by huge inter-individual variation (Griffen and Ojeda, 2000). The data in Table 3 
are consistent with that finding. Of the published reports, salivary data are available only 
for progesterone, estradiol and estriol during pregnancy. There are no published data for 
salivary estrone, testosterone or DHEAS at either time point; nor are there published data 
for postpartum progesterone, estradiol or estradiol within the first two weeks postpartum. 
There are however, unpublished clinically recognized reference ranges for non-pregnant 
women in general, supplied by AllVia Lab.
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Making comparisons between hormone values observed in this study and the 
scant published data was hindered further by limitations in the design and methodology 
employed by various investigators. First, most studies do not control for the time of day 
of sample collection and many hormones have diurnal rhythms. Test time in this study 
was very tightly controlled and all samples were collected in the morning at 
approximately 9:00 AM. Secondly, most investigators do not control for food intake even 
though food intake confounds salivary hormone analysis. All samples in this study were 
collected after an overnight fast and eating, drinking or even brushing one’s teeth were 
prohibited prior to salivary collection. Thirdly, some protocols involve the collection of 
stimulated samples where participants suck on lemon crystals or chew gum; this also 
impairs analysis by increasing salivary flow rates and ultimately hormone values. In this 
study, all samples were collected un-stimulated. Finally, most of the published reports 
utilized radioimmunoassay which, although similar to the enzyme linked immunoassay 
used in this study, produces somewhat different hormone values. Each of these factors 
made comparisons between these data and published reports especially difficult.
Nonetheless, comparisons were made for those hormones where published data 
are available. Pregnancy progesterone values for this study were not statistically different 
than those collected by Harris, et al. (1994) (p<.848). Harris et al. (1994) reported mean 
progesterone levels of 1132 pg/ml*, data from this study show mean progesterone levels 
at 1112.43 pg/ml. Pregnancy estriol values observed in this study were statistically lower 
from the mean salivary values published in the literature (p<.000), (Dame, McGarrigle
The hormone data reported by Harris et al. (1994) was reported in bi-weekly increments (36, 38 weeks) in 
SI units. Data was converted from SI (pmol/1) to conventional units (pg/ml) by dividing reported value by 
the progesterone conversion factor o f  3.18. To estimate the 37 week values, the sum o f  mean values from 
36 and 38 weeks was divided by two.
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and Lachelin, 1987; Fisher-Rasmussen, Gabrielsen and Wisberg; 1981; Kos-Kudla, et al. 
1999; Haeckel, Walker and Colic 1989; Lachelin and McGarrrigle 1984). Moreover the 
mean observed values in this study were below the range of published estriol values. The 
range of published estriol levels at 37-38 weeks of pregnancy was 922 pg/ml to 1557 
pg/ml. In this study, the mean estriol level at 37 weeks of pregnancy was 501. 96 pg/ml. 
The aforementioned issues in methodology likely account for differences between 
published values and the observed values from this study.
There are no published values for progesterone at or near 10 days postpartum; nor 
are there published values for postpartum estradiol or estriol. Furthermore, there are no 
published data for salivary DHEAS, estrone or testosterone for either pregnant or 
postpartal women. There are unpublished reference ranges for each of these salivary 
hormones for non-pregnant women. Listed in Table 4 are unpublished salivary reference 
ranges provided by AllVia Diagnostic Lab followed by the observed values for each 
hormone for both pregnant and postpartum women. Since hormone values fluctuate 
throughout a woman’s menstrual cycle, reference ranges are given for both the follicular 
(high estrogen) and luteal (high progesterone) phases of the cycle.
Obtained postpartum mean hormone values fell within lab references ranges for 
non-pregnant women. Notice that mean pregnancy values are substantially above the 
non-pregnant ranges. Notice also that, as illustrated by Table 5, with the exception of 
DHEAS, postpartum values decreased markedly from pregnancy and fell within the low 
range of the non-pregnant values. This is consistent with the widely recognized 
assumption that reproductive hormones increase exponentially during pregnancy and 
decrease precipitously within the first three to four days postpartum, continuing to fall for
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up to 30 days after delivery (Harris et al. 1998). Hormone data collected in this study 
affirmed that assumption, for the most part.
As illustrated in Table 5, progesterone levels decreased postpartum in each of the 
27 subjects. The mean change was 1095.58pg/ml or 93%. Estrone levels decreased in all 
but one participant an average of 34.33 pg/ml or 91%. In the one individual whose 
estrone increased, it did so only nominally (+.1 pg/ml). Estradiol decreased in all but three 
participants; the mean decrease was 9.96 pg/ml or 65%. Estriol, which is all but 
nonexistent in non-pregnant women, decreased in all participants with an average change 
of 98% or 452.84 pg/ml.
Testosterone increased in five participants but decreased in 21 participants. The 
average change in testosterone from pregnancy to postpartum was 17.92pg/ml or 49%. It 
should be noted, however, that the magnitude of change in testosterone was varied with 
some women showing little to no change between pregnancy and postpartum and others 
exhibiting huge differences.
Finally, unlike other studies showing serum DHEAS levels decreasing 
postpartum (Milewich, et al. 1978; O'Leary, Boyne, Flett, Beilby, James, 1991;Tagawa, 
et al. 2004; Ylikorkala, Stenman, Halmesmaki, 1988), participants in the current study 
exhibited a net increase of 34% or 402.03 pg/ml for salivary DHEAS. Furthermore, 
DHEAS increased in 21 of the participants and decreased in only six participants (see 
Table 5).
The postpartal increase in DHEAS is noteworthy not only because it contradicts 
currently held hypotheses, i.e. that DHEAS levels decrease postpartum (Milewich, et al. 
1978; O'Leary, et al. 1991;Tagawa, et al. 2004; Ylikorkala, et al. 1988), but also because
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DHEAS along with testosterone and estradiol form what may be a dominant metabolic 
pathway linked to postpartum mood lability. Indeed, as will be discussed subsequently, 
the relationship between these hormones and negative mood was statistically significant 
and does suggest a hormonal predictor of postpartum mood dysfunction.
Summary
Data from this section of the study are consistent with the currently held view that 
progesterone, estriol and estrone levels are high toward the end of pregnancy and fall 
immediately after parturition, but question that assumption for estradiol and testosterone 
at least on an individual basis. With each of these hormones, there were postpartal 
increases in a few participants and minimal decreases in others, suggesting the possibility 
that the great decline following parturition is not necessarily accurate for all women, even 
though mean data show large postpartal declines for these hormones. Larger studies are 
needed to determine whether or not these postpartal increases occur more frequently than 
has been traditionally reported.
For DHEAS, data from this study definitely contradicts the currently held 
presumption that this hormone decreases to pre-pregnancy levels postpartum (Milewich, 
et al. 1978; O'Leary, et al. 1991;Tagawa, et al. 2004; Ylikorkala, et al. 1988). Data from 
this study clearly show, postpartal DHEAS levels increasing substantially in the majority 
of participants.
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Part Two: Mood
As reviewed previously, postpartum mood lability is often presumed in the 
literature to be a consequence of childbirth that is attributed to the drop in hormones that 
occurs in the days following parturition (Buckwalter, et al. 2001; Harris et al. 1994; 
Meakin, et al. 1995; Nott, et al. 1976; Russell, et al. 2001; Sundstrom, et al. 2003; Weick, 
1989). Anecdotal and case report research suggests that postpartum mood lability and 
dysfunction begins during pregnancy and could, if systematically measured, be identified 
antenatally. Most characterizations of postpartum mood are focused on depressive 
symptoms and, thereby, have failed to acknowledge other possible concomitant mood 
and/or somatic symptoms. Given the knowledge of hormonal actions on brain circuits 
reviewed previously and the subsequent behavioral changes known to be associated with 
those actions, it seems possible that both pregnancy and postpartum are marked by 
specific but different constellations of mood changes. It seems feasible that these changes 
are characterized to some extent by active anxiety type symptoms in addition to those of 
the depressive type.
In order to fully understand perinatal mood, the present study measured the full 
spectrum of mood changes likely associated with pregnancy and postpartum. This was 
accomplished using the standardized clinical assessment scale, SCL-90R. Results from 
the SCL-90R were analyzed separately for pregnancy and postpartum and were compared 
to the normative data of other female non-psychiatric patients as provided by the authors 
of the SCL-90R (Derogatis, 1994). To determine what extent hormonal factors modulate 
affective functioning, each of the nine mood domains and the global severity index were 
compared to each of the hormones at each test time. Finally, in an attempt to identify
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antenatal predictors of postpartal mood dysfunction, hormone levels during pregnancy 
were correlated with postpartum mood.
M ood to Normative Data Comparisons
The SCL-90R manual (Derogatis, 1994) provides normative T-scores to which all 
mood data comparisons in this study were made. Each of the mood domains has a mean 
T-score of 50 with a standard deviation of 10. A T-score of 60 is equivalent to a 
percentile rank of 84, suggesting that scores one standard deviation above the mean are 
indicative of relatively high distress levels. Listed in Table 6 are mean T-scores for each 
of the symptom domains measured by the SCL-90R during pregnancy and postpartum.
Looking at the scaled T-scores, one notices that as a group, pregnant and 
postpartum women score closely to or slightly above the mean in each of the mood 
domains and that, as a group, negative mood appears to improve slightly postpartum in 
most of the domains. For example hostility, paranoia, somatization, obsessive 
compulsiveness, interpersonal insensitivity and depression all improve postpartum. Only, 
anxiety, phobia and psychoticism worsen postpartum.
The general assumptions regarding perinatal negative mood are that mood 
deteriorates postpartum and that depressive symptoms predominate, hence the popular 
nomenclature postpartum depression. The obtained data presented in Table 6 challenge 
both assumptions. Not only do mean depression scores improve postpartum (although not 
significantly p<.403), but as Table 6 illustrates, the range of mood symptoms is broad 
during pregnancy and postpartum. This may be seen more clearly by dividing the women 
into groups based upon the direction of the mood change from pregnancy to postpartum. 
As Tables 7 and 8 illustrate, there are three distinct groups of women, those whose moods
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improve postpartum, those whose mood symptoms were stable across time and domain 
and those whose moods worsen. Thus, the data obtained in this study show that as often 
as not mood changes either remained stable or improved postpartum. Caution is 
suggested however, since only 10-15% of women experience postpartum depression with 
approximately 1-3 out of 1000 exhibiting severe psychotic symptoms. In a sample of 28, 
it is likely that only three women would be expected to exhibit significant negative 
symptoms and it is unlikely that any of the participants would experience the severity of 
symptoms associated with postpartum psychosis. This was in fact the case. Of the 28 who 
completed the sample, two participants experienced severe postpartum mood dysfunction 
and one participant who failed to complete the study did so because of expressed 
postpartum mood difficulties.
Dividing the women into groups based upon direction of symptoms change brings 
to bear several factors that were not necessarily visible in the total group analyses. First, 
mood scores for those women whose moods remained stable from pregnancy to 
postpartum (Table 8) hovered around or below mean scores compared to the SCL-90R 
female non-patient normative sample, except for depression scores which were at their 
worst almost one standard deviation above mean normative scores for all three groups. 
For the stable group, the mean depression score was 59.5. For the improved group, the 
pregnancy depression score was 61.21 while the postpartum score was 54.79. For the 
group that worsened postpartum, pregnancy depression was measured at 58.5 and 
increased to 64.83 postpartum. This suggests that depressive symptoms are likely a 
component of the perinatal experience as argued by most investigators and that 
depression does worsen postpartum for some but by no means all women.
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Secondly, also from Table 8, it is apparent that the mood scores of women whose 
symptoms were stable across test times fell close to or below the lowest mean scores of 
both of the other two groups. It is possible that in these women hormone changes either 
were not associated with mood changes at all or the hormone levels in these women were 
not extreme enough to illicit noticeable behavioral changes. Since the inter-individual 
range of hormones was broad, either of these explanations is possible.
Thirdly, phobic anxiety is clearly present both during pregnancy and after 
delivery. Of the women who improved from pregnancy to postpartum, improvement was 
minimal with scores still more than one standard deviation above the mean at 63.67. Of 
the women who worsened postpartum, their postpartum phobic anxiety scores were 
similar to the improved groups’ pregnancy values at 62.37.
Finally, the overall severity of distress as measured by the global severity index 
(GSI) was similarly elevated at approximately one standard deviation above the mean 
during pregnancy for both the improved and worsened groups. For those women whose 
symptoms improved, scores returned to a level identical to the stable group. For those 
women whose distress increased postpartum, their pregnancy GSI scores were similar to 
the improved groups’ scores (58.5 and 59.33 respectively) but increased to 63.38 
postpartum.
Correlations between Hormones and M ood
Given the observed and substantial changes in hormone levels from pregnancy to 
postpartum, it is reasonable to suspect that those hormone changes underlie perinatal 
mood. Accordingly, many researchers have sought to correlate reproductive hormones 
with perinatal mood dysfunction. Most have focused on progesterone and estradiol and
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their relationship with postpartum depression. As has been discussed previously, this 
study looked at five hormones and multiple mood domains both during pregnancy and 
postpartum in an attempt to not only to characterize perinatal mood and hormone changes 
but to potentially also identify early markers of postpartum mood dysfunction. Toward 
that end, data analyses in this section begin with an overview of all of the correlations for 
both time points for all participants. Subsequently, participant data were divided into the 
three groups identified previously and as illustrated in Tables 7 and 8 and were correlated 
with hormone levels.
Pregnancy Global Correlations
Considering the entire group of participants, pregnancy testosterone (n=31) and 
DHEAS (n=32) levels were significantly and negatively associated with an array of mood 
symptoms during pregnancy. Testosterone was negatively correlated with phobia (r=- 
.384, p<.05), psychoticism (r=-.410, p<.05), somatization (r=-.445, p< .05), and overall 
severity of distress (r=-.351, p<.05). What was particularly interesting with testosterone 
was the direction of the relationship. Even though testosterone levels increase 
substantially during pregnancy as most of the other hormones did, it was lower not higher 
levels of testosterone that were significantly associated with an increase in negative 
mood.
DHEAS was also linked to negative mood such that as DHEAS levels increased 
so too did negative mood symptoms. During pregnancy, DHEAS was significantly and 
positively correlated with paranoia (r=.366, p<.05) and psychoticism (r=.376, p<.05). No 
other hormone was associated with negative mood during pregnancy.
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Postpartum Global Correlations
After delivery (n=26) testosterone was no longer associated with negative mood 
in any capacity but DHEAS (n=27) was strongly and positively correlated with several 
mood domains including anxiety (r=.461, p<.05), phobia (r=.472, p<05), paranoia 
(r=.441, p<.05), psychoticism (r=.541, p<.01), somatization (r=.508, p<.01) and global 
severity of distress (r=.387, p<.05). Estradiol (n=27) was significantly associated with 
paranoia (r=.482, p<.01) and interpersonal sensitivity (r=.437, p<.01).
Summary
The results above indicate that diminished pregnancy testosterone levels and 
elevated postpartum DHEAS as well as estradiol levels play a major role in perinatal 
negative mood. These results challenge the assumption the progesterone modulates 
perinatal negative mood.
Pregnancy by Group Analyses
In addition to the correlations between hormones and mood for the entire 
participant group, women were separated into three groups based upon the direction of 
symptom change from pregnancy to postpartum.
For the group who exhibited more distress during pregnancy than postpartum, 
progesterone was negatively correlated and DHEAS was positively correlated with 
phobia (r=-.59, p<.05; r=.99, p<.02, respectively). This is particularly noteworthy 
considering that the total group analyses showed no connections between progesterone 
and any of the mood domains. Moreover, progesterone and DHEAS showed an inverse 
relationships (data not shown) suggesting perhaps that diminished progesterone was 
mediating the rise in DHEAS levels and possibly the subsequent cormections to negative
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mood for this group. Consistent with the other findings, testosterone in this group was 
negatively correlated with a host of mood symptoms including paranoia (r=-.6, p<.04), 
somatization (r=-.63, p<.005), obsessive compulsive behavior (r=-.56, p<.02), depression, 
(r=-.58, p<.03) and the GSI (r=-.76, p<.004).
The group whose mood symptoms were stable across test times also showed an 
array of correlations between hormones and mood domains. For this group, DHEAS and 
estrone were significantly correlated with anxiety (r=.87, p<.02; r= .8, p<.05); 
testosterone was correlated with interpersonal sensitively at r= .99, p<.01, but there were 
only three participants in this particular group.
The final group whose symptoms worsened postpartum, showed a statistically 
significant relationship between DHEAS and paranoia (r=.96, p<.03) during pregnancy. 
Unlike the other groups this group showed no correlations between testosterone and 
mood during pregnancy nor did they show any relationships to progesterone.
Postpartum by Group Analyses
In the group where symptoms improved from pregnancy to postpartum, a number 
of negative symptoms were still present and still strongly associated with hormones after 
delivery. Postpartum progesterone appeared to play a significant role in mood symptoms 
for this group. Progesterone was strongly and significantly associated with anxiety 
(r=.75, p<.02), hostility (r=.53, p<.04), and depression (r=.6, p<.03). Notice that the 
direction of the relationship between progesterone and mood has changed. Elevated 
progesterone is now associated with negative mood. Since progesterone levels fell so low 
postpartum, elevated progesterone is difficult to determine in absolute terms, but the 
directional change in the relationship may signal an altered route of hormone synthesis
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relative to pregnancy. This is supported by the fact that DHEAS and estrone are no longer 
associated with any of the mood domains postpartum and the relationship between 
testosterone and mood is now much more limited. Whereas during pregnancy 
testosterone was negatively correlated with a number of mood domains, it is now only 
correlated to hostility (r=-.73, p<.001). Estriol was associated with inereased 
somatization (r=.52, p<.02).
For the stable group, DHEAS was strongly associated with phobia (r=.64, p<.007) 
and paranoia (r=.73, p<.003). Increased estradiol was significantly associated with 
psychoticism (r=.63, p<.02). No other hormone was associated with a mood domain 
postpartum from this group.
In the group whose symptoms worsen postpartum increased paranoia and 
psychoticism was observed in relation to DHEAS (r==.99, p<.007; r=.78, p<.01). Estrone 
was again associated with anxiety (r=.89, p<.001) and with depression (r=.56, p<.05). 
Estriol was associated with obsessive compulsive behaviors (r=.67, r=.04) and 
testosterone was associated with anxiety (r=.64, p<.02). Notice that with this group 
progesterone was not involved in any of the negative symptoms and testosterone was 
positively associated with anxiety, but not any of the other mood domains as was the case 
with the group whose symptoms improved postpartum.
Summary
Although definitive interpretation of these results is limited by the post hoc nature 
of these assignments, the group analyses preliminarily suggests that there are three 
distinct subsets of perinatal mood each differentially mediated by a distinct hormonal
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pattern. Further proactive studies with larger samples are needed to confirm and fully 
explore these patterns.
Possible Hormonal Predictors o f  Postpartum Negative M ood
Global Correlations
One of the goals of this research was to look for pregnancy biomarkers of 
postpartum mood dysfunction. To do this, pregnancy hormone levels for the entire group 
of participants, were correlated with postpartum mood. Consistent with the previously 
discussed findings, diminished testosterone during pregnancy was associated with 
negative mood postpartum. Testosterone (n=26) was negatively correlated with almost 
every mood domain including anxiety (r=-.469, p<.05), hostility (r=-.609, p<.001), 
psychoticism, (r=-.411, p<.05), somatization, (r=-.497, p<.05), obsessive compulsive 
behavior (r=-.589, p<.01), interpersonal sensitivity (r=-.642, p<.001), depression (r=- 
.471, p<.05) and overall distress (r=-.628, p<.001). Diminished pregnancy (n=27) 
estradiol was also correlated to increased postpartum depression scores (r=-.422, p<.05).
Group Analyses
Analyses by group indicated that the group whose symptoms improved 
postpartum was clearly affected postpartum by diminished pregnancy levels of 
testosterone whereas the group whose symptoms worsened postpartum was not. In the 
former group, diminished pregnancy testosterone was correlated with increased anxiety 
(r=-.67, p<.05), hostility, (r=-.74, p<.001), psychoticism, (r=-.88, p<.02), somatization, 
(r=-.7, p<.001), obsessive compulsive disorder (r=-.7, p<.02), interpersonal sensitivity 
(r<-.58, p<.009), depression (r=-.69, p<.009) and the severity of mood disruption as 
measured by the global severity index (r=-.84, p<.0001).
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The group whose symptoms worsened postpartum showed an altogether different 
pattern of hormone to mood correlations, perhaps due to the smaller sample size in this 
group for each of the mood domains (n = 4-12). Testosterone was not associated with any 
mood domain. Elevated DHEAS levels were noticeably but not significantly associated 
with paranoia and obsessive compulsive behavior. Estrone was associated with paranoia 
(r=.96, p<.04) and estriol was negatively associated with depression (r=-.66, p<.02).
Although these data appear contradictory, they are not because each group 
exhibited distinctly different hormone values during pregnancy. For example mean 
testosterone levels for the group whose anxiety symptoms improved postpartum was 
much higher than the group whose symptoms worsened postpartum at 41.7 pg/ml during 
pregnancy and 19.8 pg/ml postpartum compared to 29.29 pg/ml and 14 pg/ml 
respectively. For those women whose anxiety levels remained stable, pregnancy and 
postpartum testosterone levels were measured at 47.55 pg/ml and 29.7 pg/ml, 
respectively. Additionally, the range of testosterone levels within each group was huge 
so it is possible that those women who were at the lower end of the range in each group 
were those who suffered the most distress. Thus when the groups are combined, lower 
testosterone is correlated very strongly with postpartum negative mood.
Correlations between Changes in Hormone Levels to Postpartum M ood
A leading theory in the field of postpartum mood research stipulates that 
postpartum mood is related to the extreme and rapid changes in postpartum hormone 
levels following parturition. Indeed with such significant hormonal changes one would 
expect significant behavioral and physiological correlates. Most researchers thus far have 
focused on changes in progesterone and estradiol levels and have only shown weak
79
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
relationships at best. This study was much more successful, in part, because the definition 
of negative mood was not limited to depressive type symptoms and, in part, because this 
study measured multiple hormones. Thus, not only were there strong significant 
associations between estradiol and several postpartum mood domains, but consistent with 
the earlier findings outlined above, testosterone and DHEAS were again significantly 
associated with negative mood.
The magnitude of change in DHEAS, testosterone and estradiol levels from 
pregnancy to postpartum were significantly associated with multiple mood indices. 
Change from pregnancy to postpartum DHEAS levels was associated with increased 
anxiety (r=.461, p<.05) and somatization (r=.460, p<.05). The change in estradiol levels 
was associated with increased anxiety (r=.476, p<.05), hostility (r=.464, p<.05), phobia 
(r=.465, p<.05), obsessive compulsive behavior (r=.417, p<.05), interpersonal sensitivity 
(r=.557, p<.01), depression (r=.418, p<.05), and the overall severity of distress (r=.530, 
p<.01). The change in testosterone levels was associated with anxiety (r=.395, p<.05), 
hostility (r=.436, p<.05), somatization (r=.488, p<.05), obsessive compulsive behavior 
(r=.482, p<.05), interpersonal sensitivity (r=.422, p<.05) and the overall severity of 
distress (r=.522, p<.01). No other hormone was associated to any mood domain.
Previous analyses from this study indicated that lower pregnancy estradiol was 
significantly associated with elevated postpartum depression while increased postpartal 
estradiol was associated with increased paranoia and interpersonal sensitivity. Here the 
change in estradiol levels is significantly correlated with depression and with many other 
mood indices. Additionally, diminished testosterone was previously shown to be 
correlated with negative mood. Here, the change in testosterone is positively correlated
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with negative mood meaning that the larger the change in pregnancy to postpartum 
testosterone levels the greater the severity of negative mood scores.
These results are likely a result of two factors. First, in the group analysis, it was 
evident that hormones followed distinct patterns of distribution based upon the direction 
of mood change. When negative symptoms arose either in pregnancy or postpartum, 
certain hormone patterns were distinguishable when compared to participants with little 
or no negative symptoms. Thus change in direction of the correlation between estradiol or 
testosterone and negative mood does not necessarily represent an absolute change in the 
direction of the relationship. It is more likely indicative of a relative change in the overall 
balance of hormones of which both hormones are markers.
Secondly, given the change in relative values of hormones and the fact that each 
of these hormones has potent neuromodulatory effects it is likely that there is a specific 
dose-response curve relative both to the absolute amount of circulating hormone and its 
ratio to other hormones. Since both estradiol and testosterone are excitatory 
neuromodulators capable of exerting action throughout the central nervous system, it is 
possible that behaviors seen in this study relative to these hormones follow a pattern 
similar to other psychostimulants that of an inverted u-shaped curve. In such a curve, 
diminished circulating levels are associated with negative behavioral effects such as 
depression and hyper-elevated levels are associated with an increase in anxiety, paranoia 
and psychoticism and the optimal dose, whatever that may be, improves attention and 
mood.
Finally, although this is perhaps the clearest indicator of estradiol’s role in 
postpartum mood, it is possible that the connections seen between estradiol’s change
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scores and negative mood are linked more to DHEAS and testosterone insofar as 
estradiol’s synthesis is intimately tied to both testosterone and DHEAS levels.
Summary
In sum, these data suggest that it is not the ovarian hormones progesterone and 
estradiol that modulate negative mood for most women, but rather the adrenal androgens 
testosterone and DHEAS. Moreover, these data reveal that there are patterns of hormone 
to mood relationships, that, although are not fully characterized at this point, are 
definitely present and merit further investigation. Moreover, contrary to current literature 
and nomenclature, “postpartum depression” is equally likely during pregnancy as it is 
postpartum and is characterized by a spectrum of changes in mood marked largely by 
anxiety type symptoms. Finally, these results clearly illustrate that hormones are related 
to perinatal negative mood. In particular, diminished pregnancy testosterone and 
elevated DHEAS suggest an altered adrenal steroidogenic pathway associated with 
perinatal mood disorders.
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Part Three: Cognition 
Part three of this study looked at the cognitive correlates of reproductive 
hormones during pregnancy and postpartum as well as the relationship between negative 
mood and cognition.
Ample anecdotal evidence suggests that pregnant women suffer from some degree 
of memory impairment. Indeed a common complaint of many pregnant women is the 
perceived decrement in memory. Many researchers have sought to measure this deficit, 
some more successfully than others (Brindle, et al 1991; Crawley, et al. 2003; deGroot, et 
al. 2003; Sharp et al. 1993), but only one other researcher to date has attempted to link 
memory to perinatal hormones (Buckwalter et al. 1999). Moreover, only one other 
investigator has measured other possible deficits in cognitive functioning associated with 
pregnancy (Buckwalter, et al. 1999)
The purpose of this study was to provide a comprehensive picture of perinatal 
affective and cognitive functioning and connect those findings to the hormonal milieu. 
Given the breadth of influence that steroid hormones have on neural functioning 
combined with the large changes in circulating hormone levels during pregnancy and 
postpartum, it is reasonable to assume that such changes would elicit recognizable 
cognitive changes. To test this hypothesis, a comprehensive but focused battery of 
neuropsychological tests was administered to each of the participants both during 
pregnancy and within the first 10 days postpartum.
The cognitive portion of the study addressed several questions. First, are there 
measurable cognitive changes during pregnancy and postpartum as compared to 
normative samples. Secondly, are there changes in cognitive function from pregnancy to
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postpartum? Thirdly, are observed cognitive changes associated with hormonal changes 
at either time point? Fourthly, are cognitive changes associated with mood changes at 
either time point?
Test Selection
Rather than administer a broad, standard battery of neuropsychological 
instruments designed to measure gross dysfunction and, therefore, likely not capable of 
detecting what may be subtle changes in functioning, tests for this study were carefully 
chosen based upon two factors. First, the instrument had to be capable of detecting subtle 
changes in performance. This meant that it had to be sufficiently difficult so as not to 
create a ceiling effect. Secondly, the instrument had to measure cognitive function 
relative to a particular brain region. Based upon binding patterns of the hormones 
measured, two brain regions were identified as potentially susceptible to hormonal 
fluctuation. These areas included the frontal cortex, both prefrontal and motor areas, and 
the hippocampal region. Given the functional specialization of each hemisphere, it was 
important to test both left and right frontal cortex functioning as well as left and right 
hippocampal functioning. Accordingly, the tests administered in this study measured 
frontal and hippocampal functioning for both the right and left hemispheres.
Left Hippocampal and Frontal Functioning
Verbal memory is controlled in large part by the left hippocampus, with marked 
influence from the frontal cortex. The CVLT-II is a standardized, reliable and valid 
measure of several components of verbal memory arguably linked to left hippocampal 
functioning and frontal cortex functioning. The CVLT-II measures immediate recall (trial 
1-5) and recall after a distracter list (Recall B) and with a break, short and long term
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recall both unassisted (free) and cued. These recall measures are linked to hippocampal 
functioning.
Recall can be aided by frontal cortex functioning insofar as the participant is able 
to organize information and attend to the pertinent parts of the task. To determine the 
degree to which memory is helped or hindered by the frontal cortex, the CVLT-II 
assesses several domains associated with frontal functioning. These include semantic 
clustering, (categorical organization of words recalled); repetitions, (number of words 
repeated during trials, an indication of perseveration) and intrusions (number of words 
added to recall that don’t belong, a marker of disinhibition). Finally, comparing distracter 
list scores (Recall B) to trial 1 scores yields a measure of proactive interference 
demonstrating the degree of difficulty participants have in separating previously learned 
information from new information and is argued to be a particularly telling indicator of 
executive dysfunction (Egeland, et al. 2005).
CVLT-II results from this study were compared to the standard age and gender 
matched normative data provided by the test designers (Dellis, Kramer, Kaplan and Ober 
2000) as well as to age, gender and IQ matched normative data provided by Spreen and 
Strauss (1998). Comparisons to IQ adjusted normative data were based upon participants’ 
estimated average full scale IQ determined by the Barona Index as presented earlier.
By way of preview, the results from this study revealed that both pregnant and 
postpartum women performed more poorly on several aspects of verbal memory when 
compared to normative samples. When compared to IQ matched normative samples, 
performance fell substantially below what would he expected. Interestingly, performance 
declined from pregnancy to postpartum, even though most women perceived themselves
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as having improved. Detailed analysis of CVLT-II performance is presented next. The 
relevant CVLT-II data obtained in this study are shown in Table 9 with comparisons to 
age and gender matched normative data provided by test designers. Table 10 shows the 
same observed data compared to age, gender and IQ-matched samples provided by 
Spreen and Strauss (1998).
Pregnancy
During pregnancy, immediate recall varied from trial to trial, with a lower than 
normal learning curve of 1.35 words per trial that ranked only in the 39^ percentile 
compared to age and gender matched normative data. Immediate recall in the first trial 
was poor with only an average of 7.29 words recalled and a 42"“̂ percentile ranking. Total 
immediate recall across the five trials was somewhat better with the women scoring at the 
57**’ percentile. Recall on the distracter list B was poor, with participants scoring only in 
the 32"** percentile, as was the short delay free recall with scores only in the 39**’ 
percentile.
Performance in long delay was somewhat better with a 43̂ * percentile ranking. 
Cued recall, both with short and long delays, was better at the 43"̂** and 46‘*' percentiles 
respectively suggesting that verbal recognition is only nominally impaired compared to 
short and long term reeall.
Performance on indices that measure frontal cortex functioning were somewhat 
better, but still very poor compared to normative scores. Semantic clustering, a measure 
of learning strategy was slightly above average compared to age, but not education 
matched normative data, with the women scoring in the 58'*’ and 5L' percentiles for the 
immediate and long delay trials respectively. While pregnant, participants exhibited an
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abnormally elevated repetition score (67''' percentile) and showed a slightly above 
average number of intrusions (56'^ percentile). The repetition score is indicative of 
increased perseveration, while the intrusion scale suggests recall disinhibition difficulties. 
Lower list B recall scores were obtained compared to trial 1, with 6.06 (list B) versus 
7.29 (trial 1) words. The lower score on trial B indicates increased vulnerability to 
proactive interference or difficulty separating what has been learned previously from 
what needs to be learned in the new trial (Dellis, et al. 2000)
Postpartum
Performance on the CVLT-II was somewhat worse postpartum than during 
pregnancy with a few notable exceptions. The number of repetitions was significantly 
lower postpartum (p=.007), the learning curve improved, although not signifieantly, and 
semantic clustering for both short and long delays also improved, but again not 
significantly. Recall scores were Cither stable or fell and the number of intrusions 
increased although not significantly.
Comparison to IQ-Matched Normative Data
Given that the women in this study were relatively well educated, averaging 
almost 16 years of education, and exhibited a somewhat above average estimated full 
scale IQ (111) and verbal IQ (114), it was appropriate to compare their scores to age, 
gender and IQ matched normative scores. As seen in Table 10 comparisons to IQ- 
matched normative data as provided by Spreen and Strauss (1998) reveal clear and 
consistent performance deficits. Where non-lQ matched comparisons yielded slight to 
moderate deficits in verbal memory (Table 10), IQ-matched comparisons clearly 
illustrated severe deerements in verbal memory at both time points. For example
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comparisons to the IQ-matched data yielded percentile rankings from as low as the 2"̂  
percentile (immediate recall B) and the percentile (immediate total recall) during 
pregnancy to below the 1 percentile (immediate recall list B) and the S"' percentile 
(immediate total recall) postpartum.
During test administration, many women failed to organize the words 
semantically, thus hindering recall performance. As a group, semantic clustering scores 
were about average compared to normative data, but the range of scores was broad during 
pregnancy and postpartum (-2 to 9) with some women showing absolutely no ability to 
cluster the words by category, while others did quite well. Likewise repetition and 
intrusion scores were broadly distributed with scores ranging from zero repetitions or 
intrusions to as many as 16 repetitions and 18 intrusions overall.
Semantic clustering was in turn highly correlated to recall scores. Higher semantic 
clustering led to higher recall across trial with correlation ranging from r= .708, p<001 to 
r=.817, p<001 in the long and immediate recall trials respectively. Conversely, elevated 
repetition scores were associated with poorer performance on recall tasks postpartum 
with correlations ranging from r=-.493, p<.01 to r=-577, p<.01, but repetition was not 
associated with performance during pregnancy even though repetition scores were higher 
in pregnancy than postpartum (mean 7.65 vs. 4.46). The intrusion scores, although 
elevated, did not impair performance at either time point.
Changes in Verbal Memory from  Pregnancy to Postpartum
Although there were few statistically significant changes in performance from T1 
to T2 (Table 9), women performed more poorly at time T2. This is particularly interesting 
considering that most women perceived themselves as having had great improvements in
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memory from pregnancy to postpartum. Despite decrements in memory, the learning 
curve improved from 1.35 to 1.48 words per trial and total repetitions diminished 
significantly from an average of 7.65 to 4.46 words (p=.007), perhaps accounting for the 
perception of improvement. The number of intrusions increased slightly postpartum, and 
semantic clustering deteriorated. Recall on trials 1 and B declined, and proactive 
interference also increased.
Summary
The results from the CVLT-II demonstrate that pregnant and postpartum women 
have strikingly poorer verbal recall (particularly when compared to IQ-matched 
normative samples), suffer from perseveration, have difficulties with disinhibition, and 
are susceptible to proactive interference. Moreover the degree of memory impairment is 
clearly associated with the ability to categorize information. Performance postpartum was 
generally worse than during pregnancy across all recall trials, but learning curve, 
semantic clustering and perseveration improved while disinhibition and proactive 
interference increased. From these results it is evident that pregnancy and postpartum 
have deleterious effects on memory and executive function, but whether these problems 
arise from hippocampal or frontal functioning is difficult to gauge.
Right Hippocampal and Frontal Cortex Functioning
Spatial Memory
Spatial memory resides in the right hippocampus with plarming and 
organizational capacity influenced by the frontal cortex (Lezak, 1995; Cummings and 
Trimble, 1995). To determine the degree to which right hippocampal functioning was 
affected by pregnancy related hormone changes, the Rey Complex Figure Test (CFT)
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was given. This task measures multiple components of spatial memory including 
visuocontructional ability (copy task) and amount of information retained over time 
(recall). Because the figures are relatively complex, both the copy and recall components 
require a high level of organizational ability. Diminished organization is arguably linked 
to poor executive function and drastically reduces recall ability (Choi, et al. 2004; 
Gooding and Braun, 2004; Lezak, 1995; Shin et al. 2004; Spreen and Strauss 1998; 
Zappala and Trexler 1992).
The maximum score on the CFT is 36 points, with each aspect of the drawing 
given 0-2 points for accuracy and placement. The complex figure test was administered 
in both the copy and long term delay formats at both time points. To minimize practice 
effects, an alternate but comparable (Kuehn and Snow, 1992) complex figure test 
produced by L. Taylor in 1969 was utilized at T2. The CFT was scored independently hy 
two individuals with disputes resolved by a third party. Tests were scored using the L. 
Taylor scoring method and normative comparisons were made using the L. Taylor 
scoring data as provided by Spreen and Strauss (1998).
During pregnancy, copy scores were just above the mean at the 56* percentile and 
delay scores were well below normal at the 29* percentile compared to age-matched 
normative data. The mean copy score during pregnancy was 33.98 out of 36 points and 
the mean delay score was 18.2. The postpartum scores were also very low, but the pattern 
reversed. At T2 the mean copy score was 30.8, placing it in the 4* percentile, while the 
mean delay score was 20.3 placing it in the 4L' percentile. To put these scores in 
perspective, the mean pregnancy delay scores observed in this study were similar to or 
below scores that have been observed in patients with moderate closed head injuries
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(M=22.5) (Bigler, Rosa, Schultz, Hall and Harris, 1989) obsessive compulsive disorder 
(M=18.19) (Roh, et al. 2005), schizotypy (Gooding and Braun, 2004), and schizophrenia 
(M=19.2) (Penning, Mottes, Ricter-Levin, Treves and Levkovitz, 2002)
As was the case with performance on the CVLT-II, organizational ability played 
large role in performance on the CFT. Qualitative review of both copy and long delay 
performance suggests that underlying the low scores was an impressive lack of 
organizational ability and that performance on these tests may have been related more to 
diminished executive function than to reduced memory capacity, although memory is 
certainly impaired in many cases. To illustrate this point. Figures 2-8 include copy and 
recall figures from a few of the women during pregnancy as well as the original figure 
used in this task.
Notice that each of these participants failed to recognize the basic components of 
the original figure during the copy phase. They did not identify the rectangle (2) and 
forward triangle (13) as the base of the drawing, instead focused more on the individual 
details within the rectangle. By doing so they were limited in their capacity to organize 
and remember the figure appropriately in the recall trial. They also missed the contiguity 
of the horizontal (4), vertical (5), and diagonal (3) lines that cross at the center of the 
figure. This impaired recall substantially insofar as each section of each line had to be 
recalled separately rather than as part of a whole pattern. The failure to recognize the 
contiguity of the lines is evident in the recall phase where each participant remembered 
only portions of these lines. Notice also that entire sections of the figure are missing from 
each of the three figures in the recall phases. Similar problems were noted postpartum but 
are not presented. Thus failure to correctly identify and organize the inherent pattern of
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the figure impaired recall during pregnancy and may speak to some hormonal influence 
on the frontal cortex during pregnancy. Given that there were also deficits in memory it is 
also likely that hippocampal functioning was impaired. The results of the CVLT-II 
together with CFT illustrate that both right and left frontal and hippocampal systems are 
impaired perinatally.
Cognitive and Motor Processing
To determine what role pregnancy hormones might have on cognitive and motor 
processing and to rule out confounding deficits that might diminish memory 
performance, participants were given the PASAT, the Finger Tapping Test and the 
Purdue pegboard. The PASAT is a serial auditory processing task that measures attention, 
cognitive processing speed and working memory. The Finger Tapping Test and the 
Purdue Pegboard both measure motor speed and fine motor dexterity.
PASAT
The PASAT is a serial processing task in which participants are asked to add pairs 
of numbers that are read at ever increasing pace. There are four trials, with 60 numbers in 
each trial. Trial 1 is read at a pace of one number per 2.4 seconds, trials 2, 3, 4 increase to 
2.0, 1.6 and 1.2 numbers per second respectively. The PASAT requires the participant to 
add the numbers serially, without adding subsequent numbers to the sum, while retaining 
the previous number in memory. As such, the PASAT measures cognitive processing 
speed, auditory attention span and working memory (Gronwall, 1977). The PASAT is a 
demanding task thought to be especially sensitive to mild and moderate brain damage 
(Brittain, et al. 1991; Lezak, 1995).
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Published normative data for the PASAT differs somewhat between studies 
depending upon whether or not demographic variables such as gender, education, IQ and 
ethnicity are considered. Nonetheless, comparisons between the present data and 
normative data detailed in the PASAT manual (Stuss, Stethem, and Pelchat, 1988) 
indicate that during pregnaney women perform very poorly eompared to age matched 
non-pregnant normative samples. Rankings for pregnant women on PASAT ranged from 
the 22"'* to 37*'’ pereentile, by trial. After delivery, rankings improved ranging from the 
46*'’ to 52"'' pereentile, but given the possibility of praetice effects it is difficult to 
determine the nature of the improvement. Stuss, et al. report signifieant praetiee effects if 
retesting occurs six days after the first test is given.
Sinee diminished eognitive processing speed and poor auditory attention are 
likely to hinder performance on memory tasks (Dellis, et al. 2000), one would expeet 
PASAT seores to be highly correlated to CVLT-II scores. This was not the case. PASAT 
performanee was eorrelated only with the CVLT-II semantic memory scores in the 
immediate reeall eondition during pregnaney (r=.432, p<.0I5) and was not eorrelated 
with long delay semantic memory at either test time. Conversely, PASAT scores were 
eorrelated with immediate reeall scores postpartum (r=.516, p<.005) but not during 
pregnancy and showed no correlation to semantic memory. The limited and ineonsistent 
correlations between the PASAT and the CVLT-II obtained herein suggest that although 
cognitive proeessing speed was obviously diminished, as was exhibited by the poor 
performance on the PASAT, it is not likely that eognitive proeessing speed was a faetor 
on CVLT-II performance. Rather, the correlation between the PASAT and semantie
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memory suggests an attentional deficit, particularly in immediate recall where attentional 
demands are greatest.
Anecdotally, two women performed exceptionally well on the PASAT, seoring 
near 100% on each trial. Three other women were unable to complete all of the trials, 
with one of the three unable to get past the first trial, even though her math abilities and 
edueation level suggested that she should have performed otherwise.
Finger Tapping Test and the Purdue Pegboard
The Finger Tapping Test (FTT) and the Purdue Pegboard were administered to 
assess motor processing speed and lateralization. Seores obtained for the FTT in the 
present study were eompared to normative data provided by Spreen and Strauss (1998). 
The results showed motor slowing during pregnancy that improved significantly 
postpartum (p-.017) for the preferred hand and worsened non-significantly postpartum 
for the non-preferred hand. Performance for dominant and non-dominant hands during 
pregnaney yielded ranked scores in the 43^ and 45^ pereentiles respeetively. Postpartum 
performance was ranked at the 44*'’ and 38*'’ percentiles respectively.
Results from the Purdue Pegboard were compared to normative data listed in the 
Purdue Pegboard Manual. Observed performance on Purdue Pegboard was well below 
normal at both time points. Right handed performanee ranked in the 14*'’ and 19*'’ 
percentiles at pregnaney and postpartum respectively, while left-handed performance was 
ranked at the 9*'’ and 17*'’ percentiles. In each case, performance improved postpartum. 
Improvement was not significant for the right hand, but was significant for the left hand 
(p=.03).
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Overall, motor performance improved somewhat from pregnancy to postpartum. 
Preferred hand performance on the FTT improved slightly postpartum while scores from 
the non-preferred hand worsened slightly. On the Purdue Pegboard both hands improved 
slightly. Pegboard performance with both hands was not signifieantly different 
postpartum.
To assess lateralization, right-hand and left-hand scores were eompared for each 
test at each time point. For each of the tests at each test time, right-handed seores were 
signifieantly better than left-handed scores. In the FTT right-handed performance was 
signifieantly better than left-handed performance both during pregnaney (p<.000) and at 
postpartum (p<.000). For the Purdue Pegboard this was also the ease. During pregnancy 
right-handed performance was significantly better than left-handed performance (p=.001) 
as it was postpartum (p=.012). This was true for the three left handed participants as well. 
Given that all but three of the participants were right-handed these results are consistent 
with expectations and likely do not confirm or disconfirm that hormones preferentially 
affect one hemisphere or the other.
Left and Right Frontal Cortex Functioning
Verbal Fluency and Design Fluency
To further analyze the effects of pregnaney hormones on cognitive processing, 
particularly executive and hemispheric specialization, participants were given the verbal 
and design fluency tasks. Both tasks are thought to measure hemispheric frontal lobe 
function with the verbal fluency task assessing left frontal lobe functioning and the 
design fluency task measuring right frontal lobe functioning. These tasks are thought to
95
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
be particularly sensitive to dorsal lateral prefrontal cortex deficits (Cummings and 
Trimble, 1995) an area arguably susceptible to hormone influence.
The verbal fluency tests requires participants to generate words beginning with 
different letters (F, A, S) within 60 seconds. This portion of the task is referred to as 
phonemic categorization. It is followed by a semantic category task in which participants 
are required to generate animal types, again within 60 seconds. Researchers argue that the 
verbal fluency task measures both long term memory and frontal cortex functioning 
insofar as it requires participants to organize and categorize responses while 
systematically filtering irrelevant information (Abwander, Swan, Bowerman and 
Connolly 2001). Some researchers argue that it also taps long term memory insofar as 
participants are asked to retrieve words from long term storage (Raskin and Rearick, 
1996). Finally, non-impaired participants are expected to produce more words on the 
semantie rather than the phonemic task because the added structure of the semantic task 
improves retrieval (Raskin, Sliwinski and Borod 1992; Troyer, Moseovich, Winoeur, 
Alexander and Stuss, 1998).
Participants in this study performed below average on the phonemic portion of the 
verbal fluency test during pregnaney when eompared to age and edueation matched 
normative data provided by Spreen and Strauss (1998), with a mean of 44 words 
generated and a ranking in the 40^ pereentile. Participants scored above average in the 
semantic portion, with mean score of 20 words which ranked in the 58^ percentile during 
pregnaney. Postpartum performance improved non-significantly for both phonemic and 
semantic tasks, with mean seores of 46 and 21 words respectively and corresponding 
improvements in rank to the 46*'’ and 67*'’ percentiles for phonemic and semantie fluency
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tasks. At both test times the pattern of results for the scaled scores followed the expected 
pattern of performanee for non-impaired individuals (i.e. better semantic versus 
phonemic scores) but the absolute scores did not this pattern.
In the free condition of the design fluency test, participants performed just above 
average at 54* pereentile but were well below average in the fixed eondition with only a 
SS"* percentile ranking during pregnancy. The decrement in fixed condition performance 
was interesting because most participants expressed liking this task better than the free 
condition and because with the deficits in organizational ability exhibited by these 
participants, one would have expected performance here to be better. There was 
significant improvement on both tests postpartum (p-.Ol 1, p=.001, respeetively) with 
corresponding percentile rank improvements to the 77* and 63*.
Summary
Results from these tests indicate that pregnant and postpartum women exhibit 
mild to moderate impairment across all cognitive domains assessed by this battery. The 
pattern of deficit appears diffuse, contributing equally to impaired performanee on tasks 
assessing both hemispheres. Performanee on the CVLT-II when compared to age, gender 
and IQ-matched normative deficits showed moderate to severe impairment across recall 
trials bolstered only by semantic clustering abilities. Performance on the CFT indicated 
poor spatial reeall that was marked by poor visuoperceptual and constructional 
organization. Results from the PASAT demonstrated mild to moderate declines in 
attention and eognitive processing speed while performance on tests of motor processing 
were only slightly impaired. Both generative tasks illustrated mild impairment during 
pregnancy when eompared to normative data that improved somewhat postpartum.
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Cognition and Hormones
To determine if hormones were associated with the observed eognitive deficits 
seen both during pregnaney and postpartum, cognitive indices were correlated with each 
hormone at each time point. Since researchers posit that it is the magnitude of hormone 
change from pregnaney to postpartum that modulates many of the behavioral changes 
postpartum (Buekwalter et al. 1999; Harris et al. 1994), the difference between pregnaney 
and postpartum hormones was correlated with postpartum eognitive function as well. As 
was the ease with the hormone to mood relationships, the observed hormone to cognition 
relationships were complex and in some eases difficult to interpret without considering 
the biosynthetic pathways involved in hormonal regulation as well as the presumed 
neuromodulatory actions of each hormone. As will be seen, cognitive performance 
improved or deteriorated consistent with both the neuromodulatory actions of the 
hormones measured and according to the relative relationship among these hormones, but 
were not consistently eorrelated with any hormone.
The three estrogens were negatively associated with a number of cognitive indices 
during pregnaney but positively associated with other indices postpartum. Increased 
estrone during pregnaney was associated with a smaller CVLT-II learning curve (r=-.428, 
p<.05) and a lower total score on the PASAT (r=-.377, p<.05). Estradiol was negatively 
associated with immediate total reeall (r=-.389, p<.05) and estriol was negatively 
associated with trial 5 and immediate total recall of the CVLT-II (r=-.366, p<.05; r=-.385, 
p<.05) as well as trial 1 of the PASAT (r=-.379, p<.05). In each of these cases increased 
circulating levels of the hormone were associated with poor cognitive performance.
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Postpartum, estrone was not associated with any cognitive domain but estradiol 
was associated positively with trial B of the CVLT-II (r=.405, p<.05) and negatively with 
trial 2 of the PASAT (r=-.4I0, p<.05). Postpartum estriol was again associated with 
learning curve but this time the relationship was positive (r=.421, p<.05). Interestingly, 
postpartum estriol levels were very strongly and negatively correlated with performance 
on the left-handed portion of the Purdue Pegboard (r=-.532, p<.OI) as were postpartum 
testosterone levels (r=-.444, p<.05). Testosterone was also eorrelated with the number of 
repetitions on the CVLT-II during pregnaney but not postpartum. DHEAS was 
associated only with performance on the reeall portion of the CFT (r=-.379, p<.05) and 
only postpartum; it was not eorrelated with any other cognitive domain either during 
pregnaney or postpartum.
The change in circulating hormone levels from pregnaney to postpartum showed 
an altogether different pattern of association to postpartum eognitive performance and 
was more consistent with expectations based upon other findings in this study. Similar to 
findings in the mood section, the large changes in DHEAS levels were associated with 
poor performance on tests of verbal memory. In particular, the change in DHEAS levels 
was negatively correlated with immediate recall trial 5, total immediate reeall (r=-.433, 
p<.05; r=-.492, p=.01), semantie clustering (r=-.479, p<.05), and number of repetitions 
(r=-.624, p<.001). Interestingly, changes in progesterone levels showed a negative 
correlation to the number of repetitions as well (r=-.386, p<.05). The change in 
progesterone was also associated with performance on both aspects of the design fluency 
task (r=-.501, p<.01; r=-.402, p<.05).
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Summary
Given the large number of statistical analyses performed, it is possible that these 
associations are artifaetual and at the very least they are difficult to interpret. It is also 
possible that these associations are consistent with the neuromodulatory effects of the 
hormones at varying dosages and relative to their relationship with the other hormones 
measured. Reeall that estrogens are excitatory neuromodulators and should improve and 
focus cognitive ability when elevated and impair eognitive ability when diminished but 
only to a certain degree. Similar to other psychostimulants such as amphetamines, where 
lower doses improve and higher doses hinder performance, the hyper-elevated circulating 
levels of estrogen during pregnaney impaired performance, as did the extremely low 
levels of estrogens postpartum. Thus, postpartum cognitive performance improved to the 
degree that the circulating estrogens rose above the abnormally low postpartum levels. 
Likewise, pregnaney performance was impaired to the degree that estrogen levels rose 
above already abnormally high circulating levels.
The relationship between DHEAS and cognition is a lot less clear but is also 
likely attributable to an inverted u-shaped dose-response curve. Like the estrogens, 
DHEAS can be considered an excitatory neuromodulator. Indeed some studies with the 
elderly have found that DHEAS supplements improve a variety of cognitive functions 
(Berr, et al. 1996) perhaps as a result of conversion to DHEA. Sinee DHEAS levels 
decline substantially with age (Rainey, Carr, Sasano, Suzuki and Mason 2002), the 
improvement in cognitive performance reported in these studies is likely relative to the 
degree that DHEAS returns to “normal” circulating levels. In this study, DHEAS levels 
were elevated during pregnancy and increased to supra-elevated levels postpartum, thus
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the relationship to postpartum performance was tied to the magnitude of change from 
pregnaney to postpartum levels and not to absolute levels.
Overall, the hormone to cognition results from this study were expected based 
upon their neuromodulatory roles within the central nervous system. However, the results 
offer limited interpretive validity both because of the small sample size and the large 
number of correlations. It is possible that, as was the case with the mood factors, 
cognitive to hormone relationships differ by the direction of change from pregnaney to 
postpartum. That is, it is possible that there were three distinct groups of women, those 
whose performanee was better during pregnancy, those whose performance was better 
postpartum, and those who were consistent across testing times. But given the large 
number of cognitive variables and the small sample size, isolating real versus artifaetual 
relationships among the three groups would be particularly difficult.
Cognition and M ood
Each mood domain in the SCL-90R was correlated to each cognitive domain to 
determine if negative mood symptoms influenced cognitive performance. The results 
shown in Table 12 counter the currently held notion that negative mood always hinders 
eognitive performance. Except for the few negative correlations shown in Table 12, the 
relationship between negative mood and cognitive performance was positive. That is, as 
negative mood increased, cognitive performance also increased. This was true at both 
time points. Increased depression was consistently and signifieantly correlated with better 
recall call scores during pregnancy,, but no relationships were found postpartum. 
Psychotieism, phobia and paranoia also were significantly and positively correlated with 
several CVLT-II scales and were highly correlated to the fixed eondition of the design
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fluency task. Only performance on trial two of the PASAT and the learning eurve of the 
CVLT-II were negatively correlated with mood scores. Thus increases in phobic anxiety 
decreased processing speed on the PASAT (r=-.365, p<.05), and increased psychotieism 
was detrimental to the number of new words learned per trial (r=-.361, p<.05) on the 
CVLT-II.
Summary
These data indicate that negative mood does not always hinder performance on 
cognitive tasks. Indeed most mood domains showed no relationship to cognitive 
performance and many of the relationships between mood and cognition were positive.
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CHAPTER 5 
DISCUSSION
The purpose of this research was to characterize the cognitive and affective 
changes associated with perinatal hormones. Previous research had hereto presented only 
a partial picture of perinatal behavioral changes and had been unsuccessful in the attempt 
to associate those changes with perinatal hormones. This was due largely to the lack of 
sensitivity and specificity of the testing methods. The present study was able to overcome 
those issues by using more sensitive hormonal assays and a comprehensive but focused 
battery of neuropsychological instruments. Thus, data collected in this study challenge 
many of the empirical generalizations regarding perinatal hormones, mood and cognition.
Hormones and Mood 
Previous research, with the exception of Buekwalter et al. (1999), focused almost 
entirely on depressed mood as the sole marker of the postpartum experience and had 
variously sought to link depressed mood to either progesterone or estradiol (Kuevi et al. 
1983; Harris et al. 1994; O’Hara, et al. 1991; Metz et al. 1983; Nott, et al. 1976). 
Buekwalter et al. (1999) was the first and only study until now to address the possibility 
that postpartum and indeed pregnancy was likely marked by a range of mood and 
cognitive changes. The results of Buekwalter et al. (1999), although important, were 
mixed in part because hormones were assayed via serum, which measures bound rather
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than active hormone, and in part because the battery of tests given was not nearly as 
foeused as was necessary to measure what were in some eases subtle changes in 
behavior.
For the present study salivary hormone assays were used. Salivary hormone 
analysis affords a more sensitive approach than serum insofar as the active, unbound 
component of the hormone is present and measured in saliva. By increasing the 
sensitivity of hormone analyses, this study was able to confirm and challenge a number 
of findings both with regard to peripartal hormones in general and in as much as they 
relate to mood and cognition.
The general presumption about pregnancy hormones is that they increase 
exponentially until parturition where after they decrease rapidly. In the ease of 
progesterone and estriol this was in fact the case for all of the participants of this study. It 
was not the ease, however, for the other hormones. For five of the participants in this 
study, testosterone levels increased postpartum and for many others the change was not 
as substantial as would be expected. Additionally, estradiol levels increased in three of 
the participants and estrone levels increased in one participant.
Most striking were the changes in DHEAS. Previous literature measuring 
DHEAS levels in serum showed that DHEAS levels increased in the first and second 
trimesters and decreased in the third, particularly as parturition approached and fell to 
pre-pregnancy levels after delivery (O'Leary, et al. 1991; Milewieh, et al. 1978; Tagawa, 
et al. 2004; Ylikorkala, et al. 1988). This pattern of change was not observed here. 
Salivary DHEAS levels were very high at 37 weeks of pregnancy and for 21 of the 27 
women, DHEAS levels not only increased postpartum, but increased substantially. The
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increase was especially large for those women who would experience adverse postpartum 
mood changes. Thus, by measuring the unbound, bioactive component of these 
hormones, data from this study challenge the currently held assumption that all perinatal 
hormones decrease postpartum for all women.
The relationship between perinatal hormones and mood was until now only 
tenuously linked. Again by increasing the sensitivity of the hormonal assays, expanding 
the number of hormones and type of mood domains measured, this study not only 
identified putative hormonal correlates of perinatal negative mood but disputes the 
current nomenclature and diagnostic interpretation associated thereafter. Indeed what has 
hereto been called postpartum depression is not necessarily either.
Results from this study clearly demonstrate that both pregnaney and postpartum 
elicit negative mood changes for almost equal numbers of women. Moreover, although 
depression is part of the perinatal experience, it is by no means the sole determinant of 
distress. Indeed SCL-90R seores from this study were consistently elevated across 
domains at each test time. This was particularly evident in the post hoc group analyses 
where each of the two groups exhibiting distress scored approximately one standard 
deviation above the mean on most every mood domain measured. These results thus 
question 1 ) the notion that “postpartum depression” is limited to depressive symptoms 
and 2) that distress occurs solely in the postpartum period.
Moreover, results from the present study identify an unmistakable pattern of 
hormonal correlates linked to perinatal negative mood. As discussed previously, research 
in this area has been limited by definition and focus. Most research hereto performed 
attempted and failed to link postpartum depression to the ovarian hormones progesterone
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and estradiol. Given the enormous changes in these hormones from pregnancy to 
postpartum, the relationship between progesterone, estradiol, and mood suggested a 
reasonable line of inquiry. Indeed, many of the testing instruments selected for this study 
were selected based upon the presumed actions of progesterone on the GABAa receptor 
in specific regions of the central nervous system.
Based upon animal research and receptor binding patterns it was thought that 
progesterone via its actions on the GABAa receptor would mediate most perinatal 
cognitive and affective changes. Progesterone and many of its metabolites are potent 
positive allosterie modulators of the GABAa chloride channels, increasing G ABA influx 
on the postsynaptic cell. By this mechanism, progesterone is an effective sedative- 
hypnotic. Given the exponential and chronic increase in progesterone levels throughout 
pregnancy followed by the precipitous decline after parturition, it seemed likely that 
progesterone would mediate many of the affective changes associated with pregnancy 
and postpartum. This was the ease, but only for a particular group of women.
Overall, progesterone was not correlated with any of the mood domains either 
during pregnancy or postpartum, but the post hoc analyses of groups showed strong 
correlations between progesterone, anxiety, hostility, and depression postpartum for the 
group whose symptoms were worse during pregnancy; the direction of the relationship 
however, was contrary to accepted research: it was positive, indicating that increased 
progesterone was associated with increased negative mood.
These results are perplexing and may be artifaetual given the large number of 
statistical analyses performed, or they may signal some as of yet undetermined alteration 
in steroid synthesis relative to pregnancy. With such a small sample it is difficult to
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determine which of these two possibilities is true. In either case, what was clear from 
these data was that although progesterone may indirectly underlie postpartum mood, it is 
by no means the main culprit of distress. Rather, it appears from data gathered in the 
present study that adrenal androgens may underlie mueh if not all of perinatal negative 
mood, with consequent changes in each of the other hormones linked directly or 
indirectly to some fundamental change in adrenal steroidogenesis.
The most important findings of the present study were the relationships between 
the adrenal androgens DHEAS and testosterone and nearly every negative mood 
symptom measured by the SCL-90R, both during pregnancy and postpartum. In this 
study, diminished pregnancy testosterone levels were clearly, consistently and strongly 
associated with elevations in postpartal anxiety, hostility, psychotieism, somatization, 
obsessive compulsive behavior, interpersonal sensitivity, depression and global severity 
of distress. Concurrently, increases in postpartal DHEAS levels were strongly and 
signifieantly correlated with anxiety, phobia, paranoia, psychotieism, somatization and 
global severity of distress. Together, these findings present a picture of perinatal mood 
disturbance marked by increased negative mood that are identifiable biologically by 
diminished pregnaney testosterone and elevated postpartal DHEAS levels.
Given the numerous animal and molecular studies that indicate direct action by 
progesterone on the GABAa receptors, were the suppositions proposed by this and other 
researchers incorrect? No, but they were incomplete on several levels.
Recall that the metabolism of steroid hormones is tissue specific. In non-pregnant, 
normally cycling women, metabolism of steroid hormones via the ovaries and adrenals 
follows the pattern illustrated in Figure 1, wherein progesterone is converted in the
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ovaries into several other steroid hormones including testosterone, estradiol, and estrone. 
The predominant estrogen in non-pregnant women is estradiol synthesized in the ovary. 
During pregnaney and at menopause ovarian production of these hormones all but ceases, 
but circulating levels at least in the ease of pregnant women remain high (Carr, 2001; 
Walsh and Sehiff, 2001). In both instances, adrenal synthesis predominates (Walsh and 
Sehiff, 2001). In the ease of pregnant women, both the fetal and maternal adrenal glands 
produce increased levels of steroids, including those normally synthesized by the ovaries. 
The up-regulation of maternal adrenal steroid synthesis, coupled with the addition of fetal 
adrenal hormone synthesis, is presumably responsible for the elevated circulating steroid 
hormones and concomitant decrease following parturition (Carr, 2001). This makes sense 
given the quiescence of the ovaries throughout pregnancy and early postpartum.
With the perinatal shift of “ovarian” steroid hormone production, synthesis 
pathways and relative values of each hormone shift as well. Complicating factors even 
further is the fact that steroid hormone synthesis during pregnaney is a multi- 
eompartmental process wherein the relative amount of steroid produced by each 
compartment is largely dependant upon variations in enzyme availability. Although a 
full explanation of fetal maternal and placental steroidogenesis is beyond the scope of 
this study a couple of points demand discussion.
First, at approximately 6-8 weeks of gestation the fetoplacental unit takes over 
steroidogenesis (Challis and Lye, 1998). Concurrently with that development, maternal 
adrenals begin producing large amounts of DHEA, which is then converted to DHEAS 
for storage. DHEAS is the most abundant steroid in human circulation (Hammer, et al. 
2005; Siiteri, 2005; Walker et al. 2000) but is considered a reservoir for what is argued to
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be the biologically active steroid DHEA, although data from this and other studies 
suggests DHEAS may indeed be active as well (Bonser, et al. 2000; Charalampopolous, 
et al. 2005), particularly in the central nervous system. Nonetheless, according to most 
models, activation of DHEAS requires that it be converted into DHEA via microsomal 
enzymes called steroid sulfatases (Hammer, et al. 2005). Once converted to DHEA, a 
variety of other hormones via multiple enzymes are then synthesized including 
testosterone, estrone and estradiol.
This is not the pattern of steroid biosynthesis during pregnancy when the 
fetoplacental unit takes over much of the steroid production. Fetal adrenals produce 
DHEA that is also converted into DHEAS, but where DHEAS was considered inactive in 
the downstream conversion of other hormones in the adult adrenal, in the fetal adrenal 
DHEAS is the parent hormone to many other steroid hormones both directly and 
indirectly. From DHEAS produced in the fetal adrenal, estriol is synthesized. Recall that 
estriol is considered the dominant estrogen of pregnaney. Fetal adrenal DHEAS is also 
converted into multiple androgens as well as into estrone and estradiol after it is 
transferred to the placenta. During pregnancy, approximately 90% of maternal estriol 
and 50% of estrone and estradiol are derived from fetal DHEAS (Challis and Lye, 1998). 
Estriol is synthesized from DHEAS via 16 a  hydroxylation in the fetal liver while 
estradiol is aromatized from testosterone in the DHEA>androstenedione pathway. Also 
during this time, the placenta evolves as the major source of progesterone and by twelve 
weeks placental progesterone synthesis dominates (Challis and Lye, 1998).
The data from this study linking diminished pregnancy testosterone and elevated 
postpartal DHEAS to negative mood, together with shift from maternal ovarian to the
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combined fetal and maternal adrenal steroid production during pregnancy, point to altered 
adrenal androgen synthesis in the etiology of perinatal mood dysfunction. The putative 
physiological mechanism is unknown, but is conceivably linked to dysregulation of one 
of the many enzymes actively involved in steroid synthesis.
The question remains, how does DHEAS modulate behavior? Recall that 
DHEAS is a potent allosterie G A B A a antagonist and reportedly blocks G A B A a receptors 
via a mechanism similar to that of picrotoxin, making DHEAS anxiogenic and pro- 
convulsant (Jacobs, Edelheit, Coleman and Herzog, 1999; Rogers, 1999). Elevated 
DHEAS would decrease postsynaptic G A B A a Cl- influx and increase central nervous 
system excitability. The actions of DHEAS alone could account for the behavioral profile 
exhibited by the participants in this study; however, concurrent with the late term and 
postpartal rise in DHEAS levels, progesterone levels fell as well. While elevated 
progesterone is sedating and anxiolytic (Arafat, et al. 1988; Concas, et al. 1997;
Johansen, et al. 2002; Selye, 1946), both chronic progesterone exposure and abrupt 
withdrawal are highly anxiogenic (Gulinello and Smith 2003; Foley, et al. 2003;
Poromaa, et al. 2003). These two patterns are consistent with the behavioral findings of 
this study.
Even though direct evidence of DHEAS modulation of other downstream 
hormones is unavailable, there is indirect support. Research points to DHEAS facilitation 
of testosterone binding, especially albumin (Roberts, 1999). As most studies have utilized 
serum as the means to measure steroid hormones, the increased binding rather than 
absolute change in the level of hormone may or may not have heen measurable. In the 
present study, the unbound portion of the hormone was measured, hence the associations
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among DHEAS, testosterone, and negative mood. Whether there was a change in the 
absolute level of the hormone is diffieult to determine, but these data elearly show 
decreases in unbound hormone testosterone.
Thus while the assertion that progesterone levels would mediate most of the 
perinatal mood changes directly was incorrect, the presumption that G ABA modulation 
underlies many of the negative symptoms is still likely given that the pattern of 
correlations seen in this study and the direction of hormone ehapge observed from 
pregnancy to postpartum. As GABAa receptors become habituated to chronically 
elevated progesterone and receptor conformational changes ensue and as progesterone 
drops postpartum, G ABA levels are likely also to decline. Concurrently, DHEAS levels 
are rising, in some cases several fold, blocking the few GABAa receptors remaining and 
effectively increasing central nervous system excitation in the weeks leading to and 
following parturition. Moreover, pregnancy testosterone levels are possible early 
biological markers of the shift in adrenal steroidogenesis, but further research is needed 
to determine how the two are related.
Cognition
In addition to looking at perinatal mood changes, the present study measured a 
number of cognitive variables to determine if the anecdotally accepted perinatal 
decrements in memory existed, if other cognitive deficits were present and to what degree 
changes in hormones and/or changes in mood were responsible for perceived deficits. 
Unlike the mood data, the cognitive data collected herein was neither as elearly 
delineated nor as consistently tied to either hormonal or affective correlates. What was
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evident however, was that during pregnancy and when compared to normative standards, 
participants in this study performed more poorly across multiple eognitive domains 
especially in tests of both verbal and spatial memory.
When compared to age, gender and IQ-matched normative data, performance on 
the CVLT-II was well below what was expected. Indeed, as a group these women scored 
below the 20* pereentile on many variables suggesting signifieant verbal memory 
deficits. When these variables were compared either to the hormones or to the mood 
domains also measured in this study, however, no consistent pattern emerged. In fact 
during pregnancy, the most consistent relationship was between increased depression and 
better performance on a number of the CVLT-II trials.
Spatial memory as measured by the Rey CFT was similarly impaired for many of 
the participants as was evidenced hy not only quantitative means, but also by qualitative 
review. Indeed, qualitative review illustrated striking impairment in organizational ability 
in both the copy and recall portions of the task. Seores of the CFT were similarly low 
when compared to other psychiatric populations (Ashton, Donders and Hoffman, 2005; 
Fennig, et al. 2002; Gooding and Braun, 2004; Zappala and Trexler, 1992) including 
those with moderate brain injury (Bigler, et al. 1989).
Although performance on this task fell well below population mean, hormones 
and mood were relatively independent of performance. Except for the small but 
significant negative relationship between CFT recall scores and psychotieism during 
pregnancy and between recall and postpartum DHEAS levels, no other hormones or 
mood factors were associated with CFT performance. Given the level of impairment 
exhibited in each of these tasks, it is possible that small sample size contributed to the
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lack of association. It is also possible that hormones play an indirect and more subtle role 
in perinatal cognitive impairment than is currently able to be tested.
The level of impairment in both the CVLT-II and the CFT was characterized by a 
striking laek of organizational ability. This was particularly evident in the CFT where 
both eopy and recall performance was impaired. Researchers speculate that there are at 
least two types of memory disorder: the amnestic type, marked by reeall as well as 
recognition impairment, and the executive dysfunction type, marked by recall impairment 
only (Egeland et al. 2005; Penades, et al. 2005). Given that recognition was not an issue 
for these participants and recall scores were well below normal in the CVLT-II, as were 
in the CFT eopy and recall tasks, it is conceivable that perinatal memory deficits resulted 
more from executive dysfunction than amnestic factors. This would suggest more frontal 
rather than temporal impairment, although it is impossible to rule-out either completely.
If indeed perinatal eognitive is marred by executive dysfunction, concomitant mood 
changes would be characterized by either extreme mood lability and/or laek of motivation 
depending upon the region of frontal cortex most impaired (Lezak, 1995). Since mood 
lability is not measured by the SCL-90 (but is a common characteristic of perinatal 
mood), and lack of motivation is only measured as one faetor within depression domain, 
the apparent lack of association between mood and cognition is understandable, except 
that depression was positively eorrelated with CVLT-II recall. Here again, these 
correlations may be artifaetual and at the very least paradoxical for which no explanation 
is available. Despite the laek of interpretable correlation between memory and mood, 
results from this study demonstrate that perinatal mood and memory are impaired.
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Other eognitive tests showed similar decrements in performance when compared 
to normative data, but no consistent relationship with any hormone or mood factor was 
revealed. Together these data suggest that 1) perinatal eognitive deficits do exist but from 
where they arise it is not clear, 2) eognitive deficits are relatively independent of 
hormones and mood and 3) cognitive performanee is not necessarily and not uniformly 
impaired by negative mood.
Conclusion
The primary goal of this research was to elucidate the pattern of cognitive and 
affective behaviors associated with the elevated hormones of pregnaney and the 
diminished hormones following parturition and to that end, this study was very 
successful. Data from this investigation yielded the most complete picture of perinatal 
mood and cognition to date. Although statistical interpretation is marred somewhat by the 
large number of variables and the small sample size, without the comprehensive battery 
of tests many of the relationships described herein would not have been found. 
Accordingly, this study identified putative biological markers for perinatal mood 
dysfunction and in doing so challenged currently held hypotheses regarding the hormones 
and mood. Additional research is needed to fully articulate the role of adrenal androgens 
in perinatal mood.
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Tables
Table 1: Progesterone Metabolites
Progesterone Metabolites
Symbol Steroid
PI 5 P-Pregnan-3 a,20a-diol
P3 5P-Pregnan-3,20-dione (5a-DHP)
P4* 5a-Pregnan-3a-ol-20-one
P6* 5 P-Pregnan-3 a-ol-20-one
P16 SP-Pregnan-3a-ol-l 1,20-dione
P17 5p-Pregnan-3a,20(5-diol
(Arafat, et al. 1988)
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Table 2: Common Postpartum Mood Symptoms.
Baby Blues Postpartum Depression Postpartum Psyehosis
Weeping Weeping Confusion/Disorientation
Irritability Irritability/Anger Agitation (motor and psychie)
Sleeplessness Anxiety/Panic Panie
Mood lability Guilt/Alienation Delusions
Despondency Mania
Extreme mood lability Severe mood lability
Low sex drive/marital discord Suieidal ideation
Forgetfulness Murderous thoughts
Fatigue
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Table 3: Hormone Values during Pregnancy and Postpartum  
Hormone Values during Pregnancy and Postpartum
pH
Progesterone
pg/ml
DHEAS
pg/ml
Estrone
pg/ml
Estradiol
pg/ml
Estriol
pg/ml
Testosterone
pg/ml
Pregnancy
Mean 6.09 1112.43 1081.75 37.57 17.50 501.96 37.48
Median 6.10 1184.80 884.10 34.80 15.90 408.50 27.95
SD 0.35 555.61 135.5 13.60 9.11 241.20 29 86
Range 1.70 2050.70 5638.50 70.80 33.10 804.30 91.70
Minimum 5.20 221.60 1089.16 1.70 6.50 199.60 2.60
Maximum 6.90 2272.30 5774.00 72.50 39.60 1003.90 94.30
n 31 31 31 31 31 31 30*
Postpartum
Mean 6.21 80.89 1462.40 3.07 6.08 11.84 19.17
Median 6.25 79.50 1104.35 2.65 3.20 11.20 15.55
SD 0.35 36.65 1062.17 2.19 6.52 4.96 18.04
Range 1.40 155.80 4160.80 11.50 27.70 17.90 77.90
Minimum 5.50 20.30 449.10 1.20 0.60 4.50 0.20
Maximum 6.90 176.10 4609.90 12.70 28.30 22.40 78.10
n 28 28 28 28 28 28 28
*One participant had undetectable testosterone levels.
All data collected at 37 weeks o f  pregnancy and within the first 10 days postpartum
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Table 4: Hormone Reference Ranges
Unpublished Salivary Hormone Reference Ranges for Non-Pregnant Women
Reference Range Pregnancy Observed Postpartum Observed
_______ pg/ml_______________ pg/ml_______________ pg/ml______
Follicular Luteal Mean Range Mean Range
Progesterone 10-250 100-600 1112.43 221.6-2272.3 80.9 20.3-176.1
DHEAS 200-2500 200-2500 1089.16 135.5-5774.00 1462.4 449.1-4609.9
Estrone .5-4.5 .5-4.5 37.57 1.7-72.5 3.07 1.2-12.7
Estradiol 1-25 .5-25 17.5 6.5-39.6 6.08 .6-28.3
Estriol .5-16 .5-16 501.96 199.6-1003.9 11.84 4.5-22.4
Testosterone 3-49 3-49 37.48 >.1-94.30 19.17 .2-78.1
119
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 5: Hormone Change Scores
Change in Salivary Hormone Levels from Pregnancy to Postpartum
Progesterone
pg/ml
DHEAS
pg/ml
Estrone
pg/ml
Estradiol
pg/ml
Estriol 
pg/ ml
Testosterone
pg/ml
Mean -1095.59 402.03 -35.71 -9.96 -452.84 -18.93
Median -1172.60 375.30 -33.60 -9.20 -361.10 -20.05
SD 556.84 957.68 13.28 10.16 218.9 34.75
Range 1998.90 5148.90 71.40 54.90 804.60 155.90
Minimum -2195.00 -1237.80 -71.30 -19.30 -982.50 -80.40
Maximum -196.10 3811.10 0.10 35.60 -177.90 75.50
Mean % 
Change -93% 34% -91% -65% -98% -49%
n 27 27 27 27 27 26
By Participant Changes
No. whose
hormones
increase 0 21 1 3 0 5
No. whose
hormones
decrease 27 6 26 24 27 21
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Table 6: SCL-90R Scores
Mean T-scores during Pregnancy and Postpartum for the SCL-90R
Mean SD Min Max Mean SD Min Max
Pregnancy Postpartum
Anxiety 53.53 10.40 37.00 79.00 5L82 11.63 37.00 80.00
Hostility 56.25 6.89 42.00 74.00 52.89 7.52 42.00 64.00
Phobia 53^3 8.12 48.00 76.00 56.50 8.77 48.00 76.00
Paranoia 48.94 6.67 43.00 62.00 47.75 6.08 43.00 66.00
Psychoticism 52.13 6.98 47.00 71.00 54.64 8.19 47.00 71.00
Somatization 60.06 8.55 41.00 80.00 55.39 10.44 35.00 80.00
Obsessions & 
Compulsions 61.23 849 44.00 80.00 58.00 9.95 37.00 80.00
Interpersonal
Sensitivity 55.13 7.18 39.00 69.00 52.54 8.77 39.00 67.00
Depression 60.44 5j# 51.00 71.00 59.43 8.91 38.00 74.00
Global Severity 58.78 7.23 46.00 76.00 5632 9.64 33.00 76.00
n= 32 n=28
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Table 7: SCL-90R by Direction o f Change-Totals
Mood Changes from  Pregnancy to Postpartum
ANX HOS PHOB PAR PSY SOM OC IS DEP
Number
Improved 9 14 3 11 6 20 17 19 14
Number
Stable 7 5 17 12 13 2 2 3 2
Number
Worsened 12 9 8 5 9 6 9 6 12
122
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 8: SCL-90R by Direction o f Change by Mood
SCL-90R Scores by Direction o f  Change
Improved Stable Worsened
Pregnancy Postpartum Both Pregnancy Postpartum
Mean SD Mean SD Mean SD Mean SD Mean SD
Anxiety 58.11 10.34 47.77 9.09 47.14 9.26 54.42 10.28 62.25 833
Hostility 59.73 7.09 49.80 7.67 51.67 4.32 5439 6.70 60.57 2.70
Phobia 66.67 3.51 63.67 5.13 52.47 8.54 52.13 5.77 62.37 4.69
Paranoia 54.64 4.80 47.82 4.47 44.92 3.70 48.00 8.27 54.40 6.95
Psychoticism 61.50 6.47 55.67 7.06 48.69 4.13 52.44 6.46 62.56 6.42
Somatization 61.05 7.45 53.00 7.95 53.00 16.97 56.50 10.63 64.17 13.17
Obsessions & 
Compulsions 62.76 8 80 55.71 9.95 5330 4.95 58.22 9.95 6333 9.21
Interpersonal
Sensitivity 57.53 56.26 51.21 8.20 48.75 9.60 54.33 838 60.83 545
Depression 61.21 6.74 54.79 9.09 59.50 21.20 59.83 635 64.83 6.19
Global Severity 59.33 7.65 53.50 936 53.50 334 58.50 8.21 63.38 8.03
123
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 9: Mean CVLT-Il Scores
Mean CVLT-IIScores during Pregnancy & Postpartum Compared to Non IQ- 
Matched Normative Scores
Difference
Pregnancy z- score Postpartum z-score T 1-T2_______
Mean SD Mean Centile Mean SD Mean Centile tobs Sig.
Immediate
Recall Trial 1 7.29 1.63 -0.18 42.86 6.79 1.91 -1.05 30.85 1.86 0.074
Immediate
Recall Trial 5 12.84 1.88 -0.45 32.64 12.93 1.59 -0.39 34.83 -0.15 0.88
Immediate
Recall Total 53.48 7.64 57.00 53.96 6.56 -1.39 57.00 -0.41 0.96
Immediate
Recall B 6.06 2.04 -2.04 31.72 5.61 1.66 -2.49 0.64 0.94 0.36
Short Delay
Free 11.35 2.28 -1.46 39.72 11.61 2.47 -1.24 24.20 -0.07 0.94
Short Delay
Cued 12.51 2.40 -0.16 43.64 12.53 2.28 -0.30 38.21 0.2 0.841
Long Delay
Free 12.58 2.24 -1.02 47.00 11.96 2.44 -1.53 38.21 1.55 0.13
Long Delay
Cued 13.23 2.20 -0.08 46.81 12.60 2.53 -0.43 25.46 1.54 0.14
Semantic
Clustering IR 1.51 2.12 0.21 58.32 2.59 2.34 0.18 57.14 -1.78 0.09
Semantic
Clustering LD 3.94 2.94 0.03 51.20 4.56 2.66 -0.05 48.01 -0.631 0.53
Total
Intrusions' 2.13 3.45 -0.15 56.36 2.68 4.22 -0.03 59.10 -0.66 0.52
Repetitions' 7.65 4.41 0.46 66.64 4.46 3.71 -0.38 41.68 2.89 0.007
Learning
Curve 1.35 0.55 -0.27 39.36 1.48 0.62 -0.05 46.01 -1.13 0.27
“Positive intrusion and repetition scores indicate poorer performance. IR, immediate recall; 
LD, long delay.
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Table 10: CVLT-II Scores compared to IQ-Matched Norms
Mean CVLT-II Scores during Pregnancy & Postpartum  
Compared to IQ-Matched Normative Scores
Pregnancy z- score Postpartum z-score
Mean SD Mean Centile Mean SD Mean Centile
Immediate 
Recall Trial 1
Immediate 
Recall Total
Immediate 
Recall B
Short Delay 
Free
Long Delay 
Free
semantic 
Clustering 
Long Delay
Total
Intrusions
7.29 1.63 -0.18 21.48 6.79 1.91 -1.05 14.69
53.48 7.64 -1.47 7.08 53.96 6.56 -1.39 8.23
6.06 2.04 -2.04 2.07 5.61 1.66 -2.49 0.64
11.35 2.28 -1.46 7.21 11.61 2.47 -1.24 10.75
12.58 2.24 -1.02 15.39 11.96 2.44 -1.53 6.30
3.94 2.94 0.03 51.20 4.56 2.66 -0.05 48.01
2.13 3.45 -0.15 44.04 2.68 ' 4 .22 -0.03 48.80
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Table 11: Cognition and Mood
Correlations between Cognition & Mood
____________________Pregnancy___________________  ________ Postpartum________
ANX PHOB PAR PSY SOM IS DEP PAR PSY IS DEP
Verbal Memory 
Immediate
Recall Total -  -  -  -  -  -  *.359 -  -  -  -
Immediate
Recall B _ _ _ _ _ _  *.389 *.432 -  -
Short Delay *.415 -  -  *.418 -  -  *.434 -  -  -  -
Learning Curve -  -  *-.361 -  -  -  -  -  -  -
Semantic
Clustering -  -  -  -  -  -  *.420 -  -  -  -
Attention &
Processing
PASAT 2 -  *-.365 -  -  *-.362 -  -  -  -  -
Spatial Memory
Copy _  _  _  *-.368 _  _  _  -  -  — -
Motor
Processing
Purdue Both — — — — — — — *.390 — — —
Frontal Cortex
Design Fixed -  *.405 **.477 ______ *.434 *.435______ -  *.399 *.444 *.505
*p<.05
**p<.01
***p<.001
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FIGURES
Figure 1
Steroid Biosynthesis
Choesterol
Pregnenelone Androstenediol17a-OH-pregnenelone DHEAAdrenals
Ovaries 17a-OH-progesterone Androstenedione Testosterone
Deoxycorticosterone 11-Deoxycortisol 17p-Estradiol
Corticosterone | Cortisol
r
18-OH-Cosrt icosterone Aldosterone I
Estriol
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Figure 2
Key Complex Figure-Original
Figure 3
Participant A-Copy
Participant A is a high school math teacher, with 18 years of education^
All figures reduced to 50% o f  original size.
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Figure 4
Participant A-Recall
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Figure 5
Participant B-Copy
Participant B is a lawyer with 19 years of education.
7y,
_\J
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Figure 6
Participant B- Recall
Figure 7
Participant C-Copy
Participant C was a clerical administrator with 14 years of education.
Figure 8
Participant C- Recall
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Social/Behavioral IRB - Full Board Review 
Approval Notice
DATE: June 23,2004
TO: Dr. Douglas P. Ferraro
Psychology Department
FROM: Dr. Michael Stitt, Chair /
UNLV Social/Behaviorm Sciences Institutional Review Board 
via the Office for the Protection of Research Subjects
RE: Protocol Title: Cognitive and Affective Correlates of Reproductive Hormones
OPRS# 0406 -1251
This memorandum is notification that the UNLV Social/Behavioral Sciences Institutional Review 
Board reviewed and approved the subject protocol. Research on the project may proceed once you 
receive a hardcopy of this memo fiom OPRS. This «qrproval is effective fiom June 23,2004, the date 
of IRB tqiproval, through June 2,2005 a period of one year from the initial IRB review.
Should the use of human subjects described in this protocol continue beyond June 2,2005, it will be 
necessary for you to request an extension and undergo continuing review. Should you initiate any 
changes to the protocol, it will be necessary to request additional approval for such change(s) in 
writing throuÿi the Office for the Protection of Research Subjects.
If you have questions or require any assistance, please contact the Office for the Protection of 
Research Subjects at OPRSHumanSubjects@ccmail.nevada.edu or call 895-2794.
Offk» lor the Protecfion of Research Subjects (OPRS)
4S05 Maryland Parkway Box 451037
Las Vegas. NV 89154-1037
Office C702) 895-2794 Fax (702) 895-0805
Research Administration Building 104 M/S 1037 
Email: OPRSHumanSubjects@ccmaH.nevada.edu 
Website: http://www.unlv.edLi/Research/OPRS/ 
Directions: Campus Map #63
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UNLV
Social/Behavioral IRB -  Fuii Board Review 
Continuing Review Approved
P l e a s e  h e  a w a r e  t k i i i  a  p r o i o e o i  v i o i a h u n  ( e . g . ,  f a i l u r e  t o  s u h n n !  a  m o d i f c a i i o n  J a r  a i i v  c k u n g e i  o f  a n  
1 R S  a p p r o y e d p r o t o c o l  r i i i p  r e s u l t  i n  m a n d a i o r y  r e m e d i a l  é d u c a t i o n  W r i  h i "  s . r e - c o n s e v . t m g
s u b j e c t s ,  r e s e a r c h e r  p r o b a t i o n  s u s p e n s i o n  o f  a n y  r e s e a r c h  p r o t o c o l  s u  i t  p i  î o n  o f  a d d i r i o n a l
e x i s t i n g  r e s e a r c h  p r o t o c o l : , ,  i n ' . ' a i i d t n i o r :  o f  a l l  r e s e a r c h  c o n d u c t e a  11  t  > c s c u r c h  p r o t o c o l  a t  . 
i s s u e ,  a n d  f a r t h e r  a p p r o p r i a t e  c o n s e q u e n c e s  a s  d e t e r m i n e d  b y  t h e  . I R  i  i  >i s  u n t i l  O f f i c e r .
DATE: M ay  1 8 .2 0 0 5
TO: Dr. Douglas Ferraro, Psychology Dspailmem
FROM: Office for the  Protection of Research Subjects
RE: Notiitcation o f  IRB .Action MAY j a m
Protocol Title: Cogultive and Affective C o r re la te s  o f  Reproductive Hormones 
Protocol #: 0406-1251
Corainuing review o f  the protocol ttatned above has been reviewed and approved.
This IRB action will reset yottr expiration date for this protocol. The protocol is approved for a period 
o f  one year from the dale o f  IRB approval. The new expiration date for th is protocol is May 12, 2006.
P L E A S E  N O T E :
Attached to this approval notice is the official In fo n n e d  C o n sen t/A ssen t (1C.T.A) F o rm  for this study. 
T he IC /IA  con ta ins an official approval stamp, Only copies o f  this official IC T A  form may be used 
w hen obtaining consent. Please keep the original for your records.
Should there be any change to the protocol, it will be necessary’ to subm it a M o d if ic a tio n  F o rm  
through OPRS. No changes may be made to the existing protocol until modifications Itave been 
approved by the IRB.
Should th e  u se  o f  hum an sub jec ts described in th is protocol con tinue beyond M ay 12. 2006 , it w ould
be necessary to submit a C.ontiuuing Review Request F o rm  60 days before the e.xpiration date.
I f  you have questions or require any assistance, please contaci the Office for the Protection o f Research
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UNIVERSITY OF NEVADA, LAS VEGAS 
DEPARTMENT OF PSYCHOLOGY 
INFORMED CONSENT FORM
1. Introduction: You are being asked to participate in a study being conducted by 
Chandler Marrs, MS, from the Psychology Department at the University of 
Nevada, Las Vegas. The study will look at the role of pregnancy hormones on 
cognition and mood.
Procedure: If you agree to participate in this study, you will be given a variety of 
tests that measure mood and cognitive abilities in learning, memory, attention and 
motor coordination. You will also be give hormone tests, which will require you 
to spit into a test vial. The saliva will then be analyzed to determine the levels of 
several hormones (progesterone, estrone, estradiol, estriol, testosterone, and 
DHEAS). Tests will be given first at 37 weeks of your pregnancy and then 
sometime within the first 10 days postpartum.
All of the mood and cognitive test are paper-and-pencil tests. Most are quite easy 
while others may seem more difficult. Some have time limits while others do not. 
Tests of learning and memory will ask you to learn and remember words or 
designs. Tests of attention will require you to add numbers in a sequence. Tests 
of planning will require you to copy complex figures. Each testing session will 
take approximately 1.5 hours to complete. You will be provided with rest breaks 
as needed. You will not receive individual feedback after the testing, but you will 
be given information on how to contact the researchers when the project is 
completed to receive the general results of the project.
2. Benefits of Participation: By participating in this study you will be adding to the 
understanding of the cognitive and mood changes associated with pregnancy and 
postpartum. This could lead to identifying early markers and treatment for 
postpartum mental illness.
3. Risks of Participation: There are minimal risks to you from participating in this 
study, apart from possible fatigue and/or boredom. You may experience some 
test anxiety, but the tests will not be administered in a stressful manner. You are 
encouraged to inform me of any discomfort or anxiety that may occur as a result 
of the testing procedures. I will try to answer any questions you have regarding 
the tests without invalidating the procedures.
4. Cost /Compensation There will be no financial cost to you to participate in this 
study. The study will take 114 hours of your time. There is no compensation 
available for participation. The University of Nevada, Las Vegas may not provide
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compensation or free medical care for an unanticipated injury sustained as a result 
of participating in this research study.
5. Contact Information: If you have any further questions about the study or if you 
experience any harmful effects as a result of participation in this study, you may 
contact me at 895-0547 or at mom.lab@ccmail.nevada.edu.
For questions regarding the rights of research subjects, any complaints or 
comments regarding the manner in which the study is being conducted you may 
contact the UNLV Office for the Proteetion o f Research Subjects at 895-2794.
6. Voluntary Participation: Your participation in this study is strictly voluntary. 
You may refuse to participate in this study or any part of this study. You may 
withdraw at any time without prejudice to your relations with the university or 
any consequences. You are encouraged to ask questions about this study at any 
time during the study.
7. Confidentiality: All material gathered in this study will be kept private and 
confidential. No reference will be made in written or oral materials that could 
link you personally to this study at any time. All hormone samples will be coded 
using your first and last initial and month and year of birth. No identifying 
information will be given to the lab that is processing the samples. All paper 
records will be stored in a locked facility at UNLV for at least 3 years after 
completion of this study. After 3 years all records will be destroyed. All specimen 
samples will be disposed of completion of the analysis.
Participant Consent:
I have read or have had read to me all of the above information. I agree to participate
in the study. 1 am at least 18 years of age. A copy of this form has been given to me.
Signature of participant Date
Participant Name Witness
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UNLV
University of Nevada, Las Vegas
Maternal Health Lab 
Intake Form
stud y: Cognitive and Affective Correlates of Reproductive Hormones 
Date:
Participant ID#:
(first & last initial & mo/yr of birth)
Participant Information/Barona Index*
Name
DOB *Age
‘ Education ‘Occupation
‘ Race ‘White/Black/Other
Pregnancy History/Exclusionary Criteria*
Delivery Due Date Boy/Girl
‘Twins Y/N
‘ Fertility treatment Y/N ‘ Other children Y/N
‘ Head trauma Y/N
‘Current alcohol or drug u se Y/N
‘Current medical condition requiring medical attention and/or medication Y/N
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Thank-you for participating in this study. Your participation will yield important 
information about postpartum mental illness.
Instructions for Saliva Collection
1. Upon rising on the morning of testing, before eating, drinking, breastfeeding* 
or brushing teeth, place specimen vial to bottom lip and spit into vial.
2. Fill vial with at least 8 ml of saliva.
3. Close vial.
4. Clean vial with paper towel
5. Label vial with your 6-digit identification code (first initial, last initial, mm/yy of 
birth date, ex: AB0264), date and time of specimen collection.
6. Place vial in zip-lock baggie and refrigerate.
7. Specimen will be picked-up during your scheduled session.
Helpful Hints
*lf you feel that you have to breastfeed prior to specimen collection, please wait 2 
hours before attempting to spit into the vial. Please note on the label the time of 
breastfeeding and the time that the specimen was collected.
If you have difficulty producing the desired amount of salvia, imagine sucking on 
a sour lemon, or cut open a lemon (but dont eat it). The thought or sight of a sour 
lemon will initiate salivation.
Some women prefer to wrap a paper towel around the vial while spitting so as to 
collect any excess saliva.
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